https://biolegacyresearch.com/bioquant-biotox-sciences-is-now-bts-research/ 2014-04-14T23:54:52+00:00 https://biolegacyresearch.com/bts-research-attends-the-2014-aaps-national-biotechnology-conference/ 2014-05-19T23:50:32+00:00 https://biolegacyresearch.com/bts-research-attends-the-2014-aaps/ 2014-11-02T23:41:49+00:00 https://biolegacyresearch.com/bts-research-attends-the-2014-act/ 2014-11-10T23:37:39+00:00 https://biolegacyresearch.com/international-journal/ 2015-02-17T23:16:50+00:00 https://biolegacyresearch.com/wp-content/uploads/2015/10/pdf-icon1.png https://biolegacyresearch.com/amicus-briefs-dont-punish-apotex-for-complying-with-bpcia-rules/ 2016-02-03T22:30:00+00:00 https://biolegacyresearch.com/boehringer-must-turn-over-documents-to-ftc-in-wake-of-high-court-order/ 2016-02-03T22:30:00+00:00 https://biolegacyresearch.com/pentax-issues-revised-reprocessing-instructions-for-duodenoscopes/ 2016-03-03T22:40:00+00:00 https://biolegacyresearch.com/expert-iso-13485-could-cause-confusion-with-fdas-quality-system-regulation/ 2016-03-03T22:40:00+00:00 https://biolegacyresearch.com/drager-recalls-emergency-transport-ventilators/ 2016-03-03T22:40:00+00:00 https://biolegacyresearch.com/sientra-returning-all-products-to-u-s-market-following-removal/ 2016-03-03T22:40:00+00:00 https://biolegacyresearch.com/arkray-recalls-test-strips-due-to-inaccurate-readings/ 2016-03-03T22:40:00+00:00 https://biolegacyresearch.com/firm-cited-for-neglecting-mdr-reporting-patient-death/ 2016-03-03T22:40:00+00:00 https://biolegacyresearch.com/senate-help-committee-advances-scope-safety-bill-as-part-of-biomedical-innovation-agenda/ 2016-03-03T22:40:00+00:00 https://biolegacyresearch.com/cook-medical-recalls-beacon-tip-catheters/ 2016-03-03T22:40:00+00:00 https://biolegacyresearch.com/isolux-cited-for-procedural-failures-in-fda-warning-letter/ 2016-03-03T22:40:00+00:00 https://biolegacyresearch.com/form-483-hits-the-sweetspot-for-alleged-follow-up-issues/ 2016-03-03T22:40:00+00:00 https://biolegacyresearch.com/senate-confirms-califf-for-fda-top-job/ 2016-03-08T00:20:00+00:00 https://biolegacyresearch.com/france-dings-chinese-drugmaker-for-gmp-deficiencies/ 2016-03-08T00:20:00+00:00 https://biolegacyresearch.com/fda-continues-nationwide-inspections-of-compounding-pharmacies/ 2016-03-08T00:20:00+00:00 https://biolegacyresearch.com/systemic-data-manipulation-uncovered-at-indias-ipca-labs/ 2016-03-08T00:20:00+00:00 https://biolegacyresearch.com/pew-report-pushes-states-to-harmonize-compounding-standards/ 2016-03-08T00:20:00+00:00 https://biolegacyresearch.com/distributor-faces-charges-over-sale-of-alleged-counterfeit-drugs/ 2016-03-08T00:20:00+00:00 https://biolegacyresearch.com/analysis-state-rules-for-compounding-vary-widely/ 2016-03-08T00:20:00+00:00 https://biolegacyresearch.com/how-many-essential-elements-are-in-world-class-quality-agreements-try-24/ 2016-03-08T00:20:00+00:00 https://biolegacyresearch.com/fda-issues-483-to-novo-nordisk-for-inadequate-sterility-controls/ 2016-03-08T00:20:00+00:00 https://biolegacyresearch.com/eu-issues-track-and-trace-drug-packaging-rules/ 2016-03-08T00:20:00+00:00 https://biolegacyresearch.com/high-court-resistant-to-changing-damages-standard-in-patent-fights/ 2016-03-08T22:35:00+00:00 https://biolegacyresearch.com/bpcia-notification-provision-takes-center-stage-in-two-federal-cases/ 2016-03-08T22:35:00+00:00 https://biolegacyresearch.com/report-says-u-s-and-eu-generics-standards-should-be-synchronized/ 2016-03-08T22:35:00+00:00 https://biolegacyresearch.com/guidance-revises-review-standard-for-type-ii-dmfs-linked-to-andas/ 2016-03-08T22:35:00+00:00 https://biolegacyresearch.com/house-committee-grills-drug-executives-over-pricing-practices-for-generics/ 2016-03-08T22:35:00+00:00 https://biolegacyresearch.com/fda-adcommittee-backs-6-indications-for-celltrions-biosimilar-of-remicade/ 2016-03-08T22:35:00+00:00 https://biolegacyresearch.com/court-says-cashless-pay-for-delay-deals-still-risk-antitrust-suits/ 2016-03-08T22:35:00+00:00 https://biolegacyresearch.com/house-members-push-fda-cms-on-biosimilars-guidance-billing/ 2016-03-08T22:35:00+00:00 https://biolegacyresearch.com/ema-proposes-revisions-to-module-v-of-gvps-on-risk-management-systems/ 2016-03-17T21:40:00+00:00 https://biolegacyresearch.com/mylan-announces-intentions-to-buy-swedens-meda-for-7-2b/ 2016-03-17T21:40:00+00:00 https://biolegacyresearch.com/frances-ansm-dings-chinese-drugmaker-over-10-gmp-concerns-cited-at-plant/ 2016-03-17T21:40:00+00:00 https://biolegacyresearch.com/trade-deal-signing-sets-the-stage-for-new-biologics-exclusivity-policy/ 2016-03-17T21:40:00+00:00 https://biolegacyresearch.com/ema-spells-out-disclosure-policy-for-clinical-data-set-for-publication/ 2016-03-17T21:40:00+00:00 https://biolegacyresearch.com/nhs-england-plans-to-investigate-alleged-staff-ties-to-drugmakers/ 2016-03-17T21:40:00+00:00 https://biolegacyresearch.com/ema-issues-positive-recommendations-for-6-drugs-to-european-commission/ 2016-03-17T21:40:00+00:00 https://biolegacyresearch.com/celltrions-remicade-biosimilar-gets-adcomm-backing-for-6-indications/ 2016-03-17T21:40:00+00:00 https://biolegacyresearch.com/eu-issues-track-and-trace-packaging-safety-rules-to-take-effect-in-2019/ 2016-03-17T21:40:00+00:00 https://biolegacyresearch.com/warning-letter-hits-indias-ipca-labs-on-allegations-of-data-manipulation/ 2016-03-17T21:40:00+00:00 https://biolegacyresearch.com/apricus-terminates-fispemifene-clinical-program-cuts-workforce/ 2016-04-06T22:00:00+00:00 https://biolegacyresearch.com/drugmakers-back-sequenoms-stance-on-patent-eligibility/ 2016-04-06T22:00:00+00:00 https://biolegacyresearch.com/fda-accuses-7-firms-of-adding-stimulants-to-supplements/ 2016-04-07T21:55:00+00:00 https://biolegacyresearch.com/briefs/ 2016-04-07T21:55:00+00:00 https://biolegacyresearch.com/form-483-raises-gmp-concerns-about-apotek/ 2016-04-07T21:55:00+00:00 https://biolegacyresearch.com/senate-vs-house-cures-legislation/ 2016-04-07T21:55:00+00:00 https://biolegacyresearch.com/fda-sends-warning-letters-to-cis-for-deviating-from-protocols/ 2016-04-07T21:55:00+00:00 https://biolegacyresearch.com/full-issue-of-drug-industry-daily/ 2016-04-07T22:00:00+00:00 https://biolegacyresearch.com/fda-adcomm-votes-unanimously-to-recommend-intercepts-obeticholic-acid/ 2016-04-07T22:00:00+00:00 https://biolegacyresearch.com/device-tax-repeal-passes-house-industry-takes-battle-senate/ 2016-04-07T22:40:59+00:00 https://biolegacyresearch.com/ethicon-asks-fda-120-days-pull-vaginal-mesh-market/ 2016-04-07T22:42:27+00:00 https://biolegacyresearch.com/indianapolis-helmet-maker-warned-records-procedural-flaws/ 2016-04-07T22:43:07+00:00 https://biolegacyresearch.com/house-subcommittee-sets-lower-cdrh-funding-fiscal-2013/ 2016-04-07T22:45:10+00:00 https://biolegacyresearch.com/oig-many-fdaers-still-wary-air-concerns-unclear-dispute-process/ 2016-04-07T23:05:11+00:00 https://biolegacyresearch.com/syncing-fda-cms-decisions-elusive-now-official-says/ 2016-04-07T23:06:46+00:00 https://biolegacyresearch.com/court-483-nondisclosure-can-basis-class-action-lawsuit/ 2016-04-07T23:07:12+00:00 https://biolegacyresearch.com/uk-review-finds-better-device-data-might-prevent-pip-type-safety-scares/ 2016-04-07T23:07:55+00:00 https://biolegacyresearch.com/report-pip-case-highlights-mhras-need-better-medical-device-data/ 2016-04-07T23:09:47+00:00 https://biolegacyresearch.com/eu-style-device-approval-poses-patient-safety-risks-u-s-fda-says/ 2016-04-07T23:10:53+00:00 https://biolegacyresearch.com/u-s-draft-guidance-calls-pediatric-safety-tests-labeling-x-rays/ 2016-04-07T23:11:20+00:00 https://biolegacyresearch.com/herca-u-s-fda-seek-reduce-unnecessary-radiation-exposure/ 2016-04-07T23:11:44+00:00 https://biolegacyresearch.com/industry-groups-call-cmc-new-eu-labeling-requirement/ 2016-04-07T23:12:22+00:00 https://biolegacyresearch.com/tga-calls-preapproval-mainstream-medical-device-advertisements/ 2016-04-07T23:12:49+00:00 https://biolegacyresearch.com/south-africa-reworking-proposed-device-regulations-passage-may-come-year/ 2016-04-07T23:13:15+00:00 https://biolegacyresearch.com/malaysia-require-registration-medical-devices-starting-november/ 2016-04-07T23:13:43+00:00 https://biolegacyresearch.com/ghtf-updates-definition-medical-device-adds-definitions-ivd-device-accessory/ 2016-04-07T23:14:04+00:00 https://biolegacyresearch.com/pdf-files-must-comply-fda-guidance-risk-rejected/ 2016-04-07T23:23:31+00:00 https://biolegacyresearch.com/challenges-ectd-process-include-document-authoring-granularity/ 2016-04-07T23:25:18+00:00 https://biolegacyresearch.com/ten-steps-effective-ectds-every-time/ 2016-04-07T23:25:42+00:00 https://biolegacyresearch.com/abstract/ 2016-04-07T23:26:08+00:00 https://biolegacyresearch.com/countdown-2017-start-early-build-fda-compliant-ectd-system/ 2016-04-07T23:26:36+00:00 https://biolegacyresearch.com/creating-internal-framework-application-esubmission/ 2016-04-07T23:26:57+00:00 https://biolegacyresearch.com/ind-ectd-process-allows-data-submitted-collected/ 2016-04-07T23:27:26+00:00 https://biolegacyresearch.com/administrative-section-nuts-bolts-supplier-quality-agreement/ 2016-04-07T23:35:31+00:00 https://biolegacyresearch.com/tackle-issues-quality-control-contracts-operations-section/ 2016-04-07T23:36:09+00:00 https://biolegacyresearch.com/pdufa-bills-appear-authorize-fda-require-supplier-quality-accords-expert/ 2016-04-07T23:40:34+00:00 https://biolegacyresearch.com/house-subcommittee-oks-fda-2013-spending-bill-full-panel-vote-later/ 2016-04-07T23:45:24+00:00 https://biolegacyresearch.com/drug-quality-still-lacking-fda-considering-qbd-incentives/ 2016-04-07T23:46:06+00:00 https://biolegacyresearch.com/fda-wants-harder-approval-standards-drug-device-combo-diagnostics/ 2016-04-07T23:46:29+00:00 https://biolegacyresearch.com/guidance-optimizes-genotoxicity-tests-aids-risk-characterization/ 2016-04-07T23:46:53+00:00 https://biolegacyresearch.com/merck-hit-complete-response-letter-potential-sarcoma-drug/ 2016-04-07T23:48:35+00:00 https://biolegacyresearch.com/mit-engineers-develop-new-glucose-powered-implantable-medical-device/ 2016-04-07T23:54:48+00:00 https://biolegacyresearch.com/mazor-robotics-received-kfda-approval-renaissance-system/ 2016-04-07T23:55:14+00:00 https://biolegacyresearch.com/airstrip-acquires-palomar-tech-enable-mobile-ehr-access/ 2016-04-07T23:55:37+00:00 https://biolegacyresearch.com/physicians-see-medical-devices-going-mobile/ 2016-04-07T23:56:11+00:00 https://biolegacyresearch.com/indianapolis-helmet-maker-warned-records-procedural-flaws-2/ 2016-04-07T23:57:23+00:00 https://biolegacyresearch.com/prosec-protection-systems-handed-483-process-validation-lapses/ 2016-04-07T23:59:45+00:00 https://biolegacyresearch.com/api-maker-nusil-warned-quality-contamination-concerns/ 2016-04-08T00:00:01+00:00 https://biolegacyresearch.com/ema-chided-lack-transparency-pediatric-trials-waiver-process/ 2016-04-08T17:48:34+00:00 https://biolegacyresearch.com/indianapolis-helmet-maker-warned-records-procedural-flaws-3/ 2016-04-08T17:48:56+00:00 https://biolegacyresearch.com/contamination-crackdown-forces-chinese-drugmakers-halt-production/ 2016-04-08T17:49:27+00:00 https://biolegacyresearch.com/branan-medical-gets-closeout-resolving-clearance-concerns/ 2016-04-08T17:49:57+00:00 https://biolegacyresearch.com/alexza-crl-followed-483-citing-drug-storage-training-lapses/ 2016-04-08T17:50:30+00:00 https://biolegacyresearch.com/simple-cartoon-friendly-sops-lead-higher-levels-compliance-experts/ 2016-04-08T17:54:26+00:00 https://biolegacyresearch.com/ema-chided-lack-transparency-pediatric-trials-waiver-process-2/ 2016-04-08T17:54:52+00:00 https://biolegacyresearch.com/house-subcommittee-oks-fda-2013-spending-bill-full-panel-vote-later-2/ 2016-04-08T17:55:24+00:00 https://biolegacyresearch.com/teva-multiple-sclerosis-treatment-meets-goals-new-dosing-regimen/ 2016-04-08T17:55:51+00:00 https://biolegacyresearch.com/lundbeck-cut-600-jobs-europe-contain-costs/ 2016-04-08T17:56:17+00:00 https://biolegacyresearch.com/ophthotech-drug-may-shake-eye-treatment-market/ 2016-04-08T17:56:47+00:00 https://biolegacyresearch.com/raptor-pharmaceutical-announces-fda-acceptance-nda-rp103-potential-treatment-nephropathic-cystinosis/ 2016-04-08T17:57:10+00:00 https://biolegacyresearch.com/dendreon-shareholders-complain-stock-losses/ 2016-04-08T17:57:37+00:00 https://biolegacyresearch.com/biotox-sciences-attends-american-association-cancer-research-annual-meeting-2014/ 2016-04-08T17:59:38+00:00 https://biolegacyresearch.com/biotox-sciences-attends-2014-sot/ 2016-04-08T18:05:15+00:00 https://biolegacyresearch.com/acute-chronic-rodent-models-liver-fibrosis/ 2016-04-08T18:05:46+00:00 https://biolegacyresearch.com/biotox-sciences-partner-drug-development/ 2016-04-08T18:10:29+00:00 https://biolegacyresearch.com/biotox-sciences-expedient-reliable-screening-support/ 2016-04-08T18:12:26+00:00 https://biolegacyresearch.com/biotox-sciences-attends-american-association-cancer-research-annual-meeting/ 2016-04-08T18:13:26+00:00 https://biolegacyresearch.com/biotox-sciences-attends-2013-sot/ 2016-04-08T18:13:51+00:00 https://biolegacyresearch.com/biotox-sciences-introducing-new-website-biotox-sciences-bio-quant/ 2016-04-08T18:15:10+00:00 https://biolegacyresearch.com/biotox-sciences-san-diegos-best-cro-housing-vivarium/ 2016-04-08T18:15:33+00:00 https://biolegacyresearch.com/biotox-sciences-merger-acquisition-update/ 2016-04-08T18:16:26+00:00 https://biolegacyresearch.com/biotox-sciences-attends-drug-discovery-chemistry-meeting/ 2016-04-08T18:17:00+00:00 https://biolegacyresearch.com/biotox-sciences-attends-american-association-cancer-research-annual-meeting-2/ 2016-04-08T18:17:29+00:00 https://biolegacyresearch.com/biotox-sciences-attends-society-toxicology-annual-meeting-tox-expo/ 2016-04-08T18:17:55+00:00 https://biolegacyresearch.com/biotox-sciences-fda-audit-news/ 2016-04-08T18:18:27+00:00 https://biolegacyresearch.com/apricus-biosciences-sells-bio-quant-cro-subsidiary-biotox-sciences/ 2016-04-08T18:31:58+00:00 https://biolegacyresearch.com/biotox-sciences-bts-deploys-estudy-hosted-solution-management-glp-non-glp-preclinical-studies/ 2016-04-08T18:32:52+00:00 https://biolegacyresearch.com/biotox-sciences-attends-american-college-toxicology-annual-meeting/ 2016-04-08T18:41:15+00:00 https://biolegacyresearch.com/biotox-sciences-attends-american-association-pharmaceutical-scientist-annual-meeting-exposition/ 2016-04-08T18:41:48+00:00 https://biolegacyresearch.com/biotox-sciences-attends-drug-delivery-formulation-america-summit/ 2016-04-08T18:42:12+00:00 https://biolegacyresearch.com/biotox-sciences-attends-society-toxicology-annual-meeting-toxicology-expo/ 2016-04-08T18:42:38+00:00 https://biolegacyresearch.com/biotox-sciences-attends-american-college-toxicology-annual-meeting-2/ 2016-04-08T18:43:04+00:00 https://biolegacyresearch.com/biotox-sciences-attends-international-society-stem-cell-research-annual-meeting/ 2016-04-08T18:43:36+00:00 https://biolegacyresearch.com/biotox-sciences-attends-american-association-pharmaceutical-scientist-annual-meeting-exposition-2/ 2016-04-08T18:44:06+00:00 https://biolegacyresearch.com/hmgb1-studies-wound-healing-source-bio-quant-inc-hmgb1-studies-wound-healing/ 2016-04-08T18:45:29+00:00 https://biolegacyresearch.com/bio-quant-credited-xoma-poster/ 2016-04-08T18:48:23+00:00 https://biolegacyresearch.com/bio-quant-credited-trius-poster/ 2016-04-08T18:52:02+00:00 https://biolegacyresearch.com/bio-quant-announces-expansion-research-animal-diagnostic-services-cover-nine-species/ 2016-04-08T18:52:26+00:00 https://biolegacyresearch.com/fda-adds-three-chinese-drugmakers-to-import-alert-lists/ 2016-04-08T23:05:00+00:00 https://biolegacyresearch.com/senator-criticizes-fda-for-approach-to-oxilofrine-in-supplements/ 2016-04-08T23:05:00+00:00 https://biolegacyresearch.com/wuxi-apptec-lab-testing-divisions-analytical-and-stability-testing-facilities-passed-fda-inspection-2/ 2016-04-11T00:00:00+00:00 https://biolegacyresearch.com/sources-reveal-biogen-is-exploring-sale-of-hemophilia-assets-2/ 2016-04-11T00:00:00+00:00 https://biolegacyresearch.com/bregenerative-medicine-foundationb-to-highlight-need-for-new-regulatory-pathway-for-cell-therapies-at-april-12th-event-2/ 2016-04-11T00:00:00+00:00 https://biolegacyresearch.com/3-depressed-biotechs-that-investors-with-a-long-term-perspective-should-buy-right-now-2/ 2016-04-11T00:00:00+00:00 https://biolegacyresearch.com/valeant-board-of-directors-issues-statement-on-s-cooperation-with-senate-committee-on-aging-2/ 2016-04-11T00:00:00+00:00 https://biolegacyresearch.com/googles-verily-stumbles-amid-ceos-questionable-business-approach-and-ethics-allegations-2/ 2016-04-11T00:00:00+00:00 https://biolegacyresearch.com/aurora-diagnostics-inc-acquires-2/ 2016-04-11T00:00:00+00:00 https://biolegacyresearch.com/swedens-lipigon-inks-100-million-pact-with-drug-giant-astrazeneca-plc-to-identify-new-cholesterol-drugs-2/ 2016-04-11T00:00:00+00:00 https://biolegacyresearch.com/adapt-pharma-names-president-of-u-s-operations-2/ 2016-04-11T00:00:00+00:00 https://biolegacyresearch.com/bpeter-thielb-backed-south-san-francisco-firm-counsyl-cuts-27-employees-2/ 2016-04-11T00:00:00+00:00 https://biolegacyresearch.com/schnedar-steps-down-from-role-in-oc-cosgrove-takes-her-place/ 2016-04-11T20:45:00+00:00 https://biolegacyresearch.com/mhra-slams-two-indian-drugmakers-over-purported-gmp-deficiencies/ 2016-04-11T20:45:00+00:00 https://biolegacyresearch.com/french-regulator-shutters-vaccine-manufacturer-over-gmp-deficiencies/ 2016-04-11T20:45:00+00:00 https://biolegacyresearch.com/who-letter-blasts-cadila-on-data-integrity-concerns-and-gmp-issues/ 2016-04-11T20:45:00+00:00 https://biolegacyresearch.com/fda-bashes-two-indian-drugmakers-for-allegedly-flouting-procedures/ 2016-04-11T20:45:00+00:00 https://biolegacyresearch.com/quality-control-fears-prompt-letters-to-four-dietary-supplement-makers/ 2016-04-11T20:45:00+00:00 https://biolegacyresearch.com/fda-hits-compounders-with-letters-over-sterility-issues-misbranding/ 2016-04-11T20:45:00+00:00 https://biolegacyresearch.com/expert-focus-on-data-consistency-to-streamline-quality-compliance/ 2016-04-11T20:45:00+00:00 https://biolegacyresearch.com/contract-manufacturer-gets-letter-over-gmp-concerns-labeling-issues/ 2016-04-11T20:45:00+00:00 https://biolegacyresearch.com/report-surge-in-data-integrity-citations-is-tied-to-heightened-risk-of-inspections/ 2016-04-11T20:45:00+00:00 https://biolegacyresearch.com/fda-pulls-luveris-nda-at-companys-request/ 2016-04-11T22:25:00+00:00 https://biolegacyresearch.com/kalobios-announces-new-transparency-measures-for-drug-prices/ 2016-04-11T22:25:00+00:00 https://biolegacyresearch.com/abbvie-genentech-scoop-up-fda-approval-for-leukemia-drug-venclexta/ 2016-04-11T22:25:00+00:00 https://biolegacyresearch.com/senate-committee-eyes-contempt-proceedings-against-valeants-pearson/ 2016-04-11T22:25:00+00:00 https://biolegacyresearch.com/fda-consider-real-world-usage-early-on-to-avoid-medication-errors/ 2016-04-11T22:25:00+00:00 https://biolegacyresearch.com/draft-guidance-looks-to-set-record-straight-on-basics-of-data-integrity/ 2016-05-03T21:35:00+00:00 https://biolegacyresearch.com/ec-updates-device-diagnostics-harmonization-standards/ 2016-06-10T16:00:00+00:00 https://biolegacyresearch.com/theranos-voids-two-years-worth-of-blood-test-results/ 2016-06-10T16:00:00+00:00 https://biolegacyresearch.com/b-braun-to-pay-4-m-to-resolve-criminal-liability-allegations/ 2016-06-10T16:00:00+00:00 https://biolegacyresearch.com/fda-warns-german-diagnostics-maker-qiagen-for-tb-test-failures/ 2016-06-10T16:00:00+00:00 https://biolegacyresearch.com/avoid-repeat-capas-with-better-risk-management-tools/ 2016-06-10T16:00:00+00:00 https://biolegacyresearch.com/health-canada-updates-essure-labels/ 2016-06-10T16:00:00+00:00 https://biolegacyresearch.com/who-creates-device-regulatory-blueprint-for-developing-nations/ 2016-06-10T16:00:00+00:00 https://biolegacyresearch.com/jj-hit-with-lawsuits-over-alleged-pelvic-mesh-injuries/ 2016-06-10T16:00:00+00:00 https://biolegacyresearch.com/renovis-surgical-warned-over-quality-system-violations/ 2016-06-10T16:00:00+00:00 https://biolegacyresearch.com/unwrapped-cannulas-prompt-warning-for-grams/ 2016-06-10T16:00:00+00:00 https://biolegacyresearch.com/fda-letters-target-foreign-api-makers-over-data-falsification-and-deficiencies/ 2016-06-13T21:40:00+00:00 https://biolegacyresearch.com/polydrug-lands-fda-warning-letter-on-post-ban-data-integrity-claims/ 2016-06-13T21:40:00+00:00 https://biolegacyresearch.com/fda-letter-blasts-infusion-options-over-sterility-concerns-at-facility/ 2016-06-13T21:40:00+00:00 https://biolegacyresearch.com/fda-serves-four-drugmakers-with-form-483s-on-gmp-concerns/ 2016-06-13T21:40:00+00:00 https://biolegacyresearch.com/fda-letters-slam-four-compounders-over-sterility-prescription-issues/ 2016-06-13T21:40:00+00:00 https://biolegacyresearch.com/xellia-fda-modify-consent-decree-site-can-resume-production-by-2017/ 2016-06-13T21:40:00+00:00 https://biolegacyresearch.com/fda-targets-five-supplement-makers-on-claims-batch-production-records/ 2016-06-13T21:40:00+00:00 https://biolegacyresearch.com/eu-looks-to-harmonize-u-s-and-eu-rules-covering-approval-guidelines-and-gmp/ 2016-06-13T21:40:00+00:00 https://biolegacyresearch.com/european-regulators-threaten-to-pull-certificates-for-two-indian-companies/ 2016-06-13T21:40:00+00:00 https://biolegacyresearch.com/study-physicians-confused-over-biosimilar-product-differences/ 2016-06-17T18:30:00+00:00 https://biolegacyresearch.com/biocad-sues-roche-over-alleged-predatory-pricing-practices-of-biosimilars/ 2016-06-17T18:30:00+00:00 https://biolegacyresearch.com/generic-drug-complete-response-letters-finally-drop-in-may/ 2016-06-17T18:30:00+00:00 https://biolegacyresearch.com/study-generic-cancer-drugs-priciest-in-u-s-least-affordable-in-india-china/ 2016-06-17T18:30:00+00:00 https://biolegacyresearch.com/amgen-sues-sandoz-over-biosimilar-application-for-neulasta/ 2016-06-17T18:30:00+00:00 https://biolegacyresearch.com/industry-calls-on-fda-to-establish-working-groups/ 2016-06-17T18:30:00+00:00 https://biolegacyresearch.com/high-court-denies-mercks-appeal-on-cubicin-patents/ 2016-06-17T18:30:00+00:00 https://biolegacyresearch.com/european-regulators-propose-fast-tracking-generic-drugs-to-lower-prices/ 2016-06-17T18:30:00+00:00 https://biolegacyresearch.com/industry-workforce-bill-would-hinder-quality-of-biosimilar-market/ 2016-06-17T18:30:00+00:00 https://biolegacyresearch.com/fda-suggests-5-point-scale-to-measure-topical-patch-adhesion/ 2016-06-17T18:30:00+00:00 https://biolegacyresearch.com/indian-court-orders-pfizer-to-dump-soon-to-expire-quantities-of-medrol/ 2016-06-17T21:45:00+00:00 https://biolegacyresearch.com/study-drug-retail-prices-highest-in-u-s-least-affordable-in-india-and-china/ 2016-06-17T21:45:00+00:00 https://biolegacyresearch.com/amr-report-recommends-financial-incentives-for-vaccine-development/ 2016-06-17T21:45:00+00:00 https://biolegacyresearch.com/nice-gives-soft-no-to-janssens-leukemia-treatment-rejects-roches-perjeta/ 2016-06-17T21:45:00+00:00 https://biolegacyresearch.com/report-ema-approval-recommendations-rose-in-2015-cancer-drugs-doubled/ 2016-06-17T21:45:00+00:00 https://biolegacyresearch.com/france-to-tighten-clinical-trial-regulations-following-fatal-trial-ema-to-conduct-review/ 2016-06-17T21:45:00+00:00 https://biolegacyresearch.com/eu-seeks-harmonization-of-u-s-and-european-rules-on-approval-guidelines-and-gmp/ 2016-06-17T21:45:00+00:00 https://biolegacyresearch.com/two-india-drugmakers-chided-by-italian-authorities-for-gmp-issues/ 2016-06-17T21:45:00+00:00 https://biolegacyresearch.com/croatian-regulator-slams-indian-api-maker-for-32-alleged-gmp-violations/ 2016-06-17T21:45:00+00:00 https://biolegacyresearch.com/fda-accuses-two-foreign-api-makers-of-data-integrity-lapses/ 2016-06-17T21:45:00+00:00 https://biolegacyresearch.com/pfizer-signs-code-of-conduct-for-opioid-marketing-under-deal-with-chicago/ 2016-07-06T22:55:00+00:00 https://biolegacyresearch.com/fda-recalls-and-import-alerts/ 2016-07-06T22:55:00+00:00 https://biolegacyresearch.com/legislative-update/ 2016-07-06T22:55:00+00:00 https://biolegacyresearch.com/protocol-deviations-prompt-483s-for-clinical-investigators/ 2016-07-06T22:55:00+00:00 https://biolegacyresearch.com/fda-sets-compliance-framework-for-compounding-near-replicas-of-approved-drugs/ 2016-07-07T22:05:00+00:00 https://biolegacyresearch.com/fda-issues-rebuttal-to-astrazeneca-exclusivity-suit/ 2016-07-07T22:06:00+00:00 https://biolegacyresearch.com/nice-backs-pfizers-bosulif-after-cancer-fund-restructuring/ 2016-07-07T22:08:00+00:00 https://biolegacyresearch.com/week-in-review/ 2016-07-07T22:40:00+00:00 https://biolegacyresearch.com/anpac-bio-medical-science-ceo-keynote-speaker-at-monday-july-11-2016/ 2016-07-08T00:00:00+00:00 https://biolegacyresearch.com/theranos-ceo-banned-from-operating-a-lab-for-two-years/ 2016-07-08T00:00:00+00:00 https://biolegacyresearch.com/regeneron-to-report-second-quarter-2016-financial-and-operating-results-and-host-conference-call-and-webcast-on-august-4-2016/ 2016-07-08T00:00:00+00:00 https://biolegacyresearch.com/abbvies-175-million-gamble-pays-off-as-ablynx-ra-drug-meets-goal-in-phase-ii-study/ 2016-07-08T00:00:00+00:00 https://biolegacyresearch.com/st-jude-medical-settles-lawsuit-over-crm-leads-for-39-million/ 2016-07-08T00:00:00+00:00 https://biolegacyresearch.com/pfizer-stock-climbs-with-positive-renal-cancer-phase-iii-data/ 2016-07-08T00:00:00+00:00 https://biolegacyresearch.com/puretech-appoints-to-scientific-advisory-board-and-expands-team-and-advisory-group/ 2016-07-08T00:00:00+00:00 https://biolegacyresearch.com/this-neglected-big-pharma-stock-could-be-about-to-explode/ 2016-07-08T00:00:00+00:00 https://biolegacyresearch.com/ignyta-to-present-at-2016-healthcare-conference/ 2016-07-08T00:00:00+00:00 https://biolegacyresearch.com/biomarin-shoots-up-on-roche-takeover-rumor/ 2016-07-08T00:00:00+00:00 https://biolegacyresearch.com/bts-research-attend-aaps-2016-denver-colorado/ 2016-10-31T20:47:08+00:00 https://biolegacyresearch.com/ich-adopts-update-to-gcp-guideline-regional-guidances-to-follow/ 2016-12-13T21:10:00+00:00 https://biolegacyresearch.com/fda-cites-japanese-drugmaker-for-data-falsification/ 2016-12-13T21:10:00+00:00 https://biolegacyresearch.com/ema-takes-steps-to-implement-iso-standards-for-drug-identifiers/ 2016-12-13T21:10:00+00:00 https://biolegacyresearch.com/chinas-fda-verifies-data-from-55-clinical-trials-in-first-audits/ 2016-12-13T21:10:00+00:00 https://biolegacyresearch.com/fda-strengthens-guidance-on-quality-agreements-with-cmos/ 2016-12-13T21:10:00+00:00 https://biolegacyresearch.com/indian-authorities-report-27-drugs-failed-quality-tests/ 2016-12-13T21:10:00+00:00 https://biolegacyresearch.com/ema-less-data-required-for-expanding-orphan-drug-indications/ 2016-12-13T21:10:00+00:00 https://biolegacyresearch.com/drugmakers-criticize-german-proposal-to-set-drug-price-ceiling/ 2016-12-13T21:10:00+00:00 https://biolegacyresearch.com/ema-comparative-studies-not-required-for-heparin-biosimilar/ 2016-12-13T21:10:00+00:00 https://biolegacyresearch.com/ema-finalizes-guideline-on-active-chemical-substances/ 2016-12-13T21:10:00+00:00 https://biolegacyresearch.com/spanish-api-maker-lands-warning-letter-for-gmp-deficiencies/ 2017-01-17T20:30:00+00:00 https://biolegacyresearch.com/fda-hits-morton-salt-with-form-483-for-cleaning-manufacturing-violations/ 2017-01-17T20:30:00+00:00 https://biolegacyresearch.com/guidance-lists-suspect-product-scenarios-requiring-fda-notification/ 2017-01-17T20:30:00+00:00 https://biolegacyresearch.com/fda-hands-warning-letter-to-sti-pharma-for-adverse-events-reporting/ 2017-01-17T20:30:00+00:00 https://biolegacyresearch.com/sun-pharma-lands-483-as-gmp-deficiencies-continue-to-plague-facility/ 2017-01-17T20:30:00+00:00 https://biolegacyresearch.com/spanish-drugmaker-sued-for-off-label-promotion-of-thrombate-iii/ 2017-01-17T20:30:00+00:00 https://biolegacyresearch.com/two-international-drug-manufacturers-earn-warning-letters/ 2017-01-17T20:30:00+00:00 https://biolegacyresearch.com/japan-to-share-gmp-inspection-findings-on-api-makers-with-eu-fda-tga/ 2017-01-17T20:30:00+00:00 https://biolegacyresearch.com/fda-483-finds-deficiencies-at-baxter-healthcare-facility/ 2017-01-17T20:30:00+00:00 https://biolegacyresearch.com/spanish-regulator-suspends-authorization-of-drugmaker/ 2017-01-17T20:30:00+00:00 https://biolegacyresearch.com/solicitor-general-to-high-court-review-case-on-biosimilar-launch-delays/ 2017-01-17T21:45:00+00:00 https://biolegacyresearch.com/generics-makers-accused-of-fixing-prices-of-antibiotics-diabetes-drug/ 2017-01-17T21:45:00+00:00 https://biolegacyresearch.com/gilead-to-pay-merck-2-5b-in-record-patent-ruling-over-hep-c-therapies/ 2017-01-17T21:45:00+00:00 https://biolegacyresearch.com/uk-agency-actavis-inflated-prices-of-hydrocortisone-by-12000/ 2017-01-17T21:45:00+00:00 https://biolegacyresearch.com/fda-clarifies-scope-of-major-deficiencies-in-andas/ 2017-01-17T21:45:00+00:00 https://biolegacyresearch.com/kite-pharma-sued-for-infringement-of-cancer-therapy-patent/ 2017-01-17T21:45:00+00:00 https://biolegacyresearch.com/high-court-refuses-to-hear-case-on-six-month-wait-for-biosimilar-launch/ 2017-01-17T21:45:00+00:00 https://biolegacyresearch.com/teva-sues-5-generics-makers-over-copaxone-generics/ 2017-01-17T21:45:00+00:00 https://biolegacyresearch.com/ogd-generic-approvals-crls-hold-steady-as-andas-decline/ 2017-01-17T21:45:00+00:00 https://biolegacyresearch.com/ec-most-patent-settlements-continue-to-delay-generic-launches/ 2017-01-17T21:45:00+00:00 https://biolegacyresearch.com/gao-report-while-hard-to-measure-progress-in-fdas-overseas-inspections-still-hurt-by-job-vacancies/ 2017-01-18T00:29:26+00:00 https://biolegacyresearch.com/precision-interconnect-cited-for-poor-documentation/ 2017-01-18T22:45:00+00:00 https://biolegacyresearch.com/cryosurgery-hit-with-form-483-for-acceptance-quality-procedures/ 2017-01-18T22:45:00+00:00 https://biolegacyresearch.com/cures-act-encourages-breakthrough-devices-exempts-medical-software/ 2017-01-18T22:45:00+00:00 https://biolegacyresearch.com/aesculap-gets-form-483-for-untimely-reports/ 2017-01-18T22:45:00+00:00 https://biolegacyresearch.com/fda-releases-final-guidance-on-endoscope-cross-contamination/ 2017-01-18T22:45:00+00:00 https://biolegacyresearch.com/numerous-procedural-violations-leads-to-form-483-for-hoggan-scientific/ 2017-01-18T22:45:00+00:00 https://biolegacyresearch.com/united-contact-lens-cited-for-product-testing-procedures/ 2017-01-18T22:45:00+00:00 https://biolegacyresearch.com/hong-kong-issues-warnings-for-pacing-leads-stents-ventilators/ 2017-01-18T22:45:00+00:00 https://biolegacyresearch.com/cdrh-releases-list-of-guidance-documents-expected-for-2017/ 2017-01-18T22:45:00+00:00 https://biolegacyresearch.com/white-square-chemical-gets-form-483-for-poor-procedures/ 2017-01-18T22:45:00+00:00 https://biolegacyresearch.com/panoramic-corp-gets-form-483-for-reporting-failures/ 2017-01-18T22:45:00+00:00 https://biolegacyresearch.com/lack-of-corrective-action-procedures-earn-hansen-ophthalmic-form-483/ 2017-01-18T22:45:00+00:00 https://biolegacyresearch.com/inservco-inc-receives-form-483-citing-procedures-device-history/ 2017-01-18T22:45:00+00:00 https://biolegacyresearch.com/congress-receives-fdas-user-fee-reauthorization-recommendations/ 2017-01-18T23:38:07+00:00 https://biolegacyresearch.com/hhs-relaxes-proposed-common-rule-restrictions-on-biospecimen-research/ 2017-01-18T23:39:14+00:00 https://biolegacyresearch.com/inadequate-written-procedures-land-warner-chilcott-a-form-483/ 2017-01-18T23:40:33+00:00 https://biolegacyresearch.com/meeting-planner/ 2017-01-18T23:41:56+00:00 https://biolegacyresearch.com/cber-publishes-2017-guidance-agenda/ 2017-01-18T23:49:05+00:00 https://biolegacyresearch.com/stealth-biotherapeutics-release-company-announces-new-appointments-to-senior-leadership-team/ 2017-01-19T00:00:00+00:00 https://biolegacyresearch.com/glaxosmithkline-poaches-astrazeneca-plc-exec-to-replace-exiting-pharma-head/ 2017-01-19T00:00:00+00:00 https://biolegacyresearch.com/can-fite-biopharma-release-company-announces-5-million-registered-direct-offering/ 2017-01-19T00:00:00+00:00 https://biolegacyresearch.com/bmartin-shkrelisb-complaint-leads-to-a-100-million-ftc-settlement-for-this-biotech/ 2017-01-19T00:00:00+00:00 https://biolegacyresearch.com/biocept-inc-release-company-awarded-patent-in-australia-for-the-use-of-antibodies-in-microchannels-to-capture-circulating-tumor-cells-and-other-rare-cells/ 2017-01-19T00:00:00+00:00 https://biolegacyresearch.com/not-so-different-after-all-5-overlapping-skills-needed-in-life-science-academia-vs-industry/ 2017-01-19T00:00:00+00:00 https://biolegacyresearch.com/genedata-ag-release-company-launches-data-science-services-for-precision-medicine/ 2017-01-19T00:00:00+00:00 https://biolegacyresearch.com/what-and-his-potential-nominees-should-understand-about-the-fda/ 2017-01-19T00:00:00+00:00 https://biolegacyresearch.com/viewray-rakes-in-26-1-million-in-private-placement/ 2017-01-19T00:00:00+00:00 https://biolegacyresearch.com/struggling-mannkinds-new-strategy-includes-doubling-its-sales-force/ 2017-01-19T00:00:00+00:00 https://biolegacyresearch.com/bio-rad-release-company-to-report-fourth-quarter-and-full-year-2016-financial-results-thursday-february-23-2017/ 2017-01-19T00:00:00+00:00 https://biolegacyresearch.com/kaleo-release-pharma-announces-u-s-availability-and-pricing-to-patients-of-auvi-q-epinephrine-injection-usp-auto-injector-for-life-threatening-allergic-reactions/ 2017-01-19T00:00:00+00:00 https://biolegacyresearch.com/telix-pharma-release-companies-conclude-therapeutic-product-development-agreement-for-prostate-cancer/ 2017-01-19T00:00:00+00:00 https://biolegacyresearch.com/zynerba-release-company-announces-proposed-public-offering-of-common-stock/ 2017-01-19T00:00:00+00:00 https://biolegacyresearch.com/nyu-langone-medical-center-release-company-roots-of-related-genetic-diseases-found-in-cell-powerhouses/ 2017-01-19T00:00:00+00:00 https://biolegacyresearch.com/fda-says-all-off-label-communications-can-fall-within-regulatory-purview/ 2017-01-19T00:06:49+00:00 https://biolegacyresearch.com/japan-to-share-gmp-inspection-findings-on-api-makers/ 2017-01-19T20:23:55+00:00 https://biolegacyresearch.com/doj-recovers-1-2-billion-in-false-claims-from-life-science-industry/ 2017-01-19T20:24:54+00:00 https://biolegacyresearch.com/aemps-suspends-spanish-manufacturers-license/ 2017-01-19T20:26:13+00:00 https://biolegacyresearch.com/fda-plans-to-require-rems-for-opioid-painkillers/ 2017-01-19T20:27:25+00:00 https://biolegacyresearch.com/wockhardt-receives-warning-letter-over-sterility-data-integrity-concerns/ 2017-01-19T20:29:31+00:00 https://biolegacyresearch.com/califf-fda-officials-temper-expectations-for-real-world-evidence/ 2017-01-19T20:30:41+00:00 https://biolegacyresearch.com/international-drugmakers-earn-warning-letters-over-quality-controls/ 2017-01-19T20:32:56+00:00 https://biolegacyresearch.com/chinese-drugmaker-cited-for-failing-to-disclose-info-to-fda/ 2017-01-19T20:34:12+00:00 https://biolegacyresearch.com/supreme-court-will-hear-bms-appeal-on-jurisdiction-ruling/ 2017-01-19T23:55:00+00:00 https://biolegacyresearch.com/mckesson-to-pay-record-fine-of-150-million-for-not-reporting-suspicious-opioid-orders/ 2017-01-19T23:55:00+00:00 https://biolegacyresearch.com/mallinckrodt-to-settle-ftc-monopoly-charges-for-100-million/ 2017-01-19T23:55:00+00:00 https://biolegacyresearch.com/bgast-manufacturing-inc-b-release-new-greener-bgastb-pump-ranges-provide-greater-flow-and-deeper-vacuum/ 2017-01-20T00:00:00+00:00 https://biolegacyresearch.com/who-might-or-might-not-buy-regeneron-and-why/ 2017-01-20T00:00:00+00:00 https://biolegacyresearch.com/ethicon-release-company-announces-acquisition-of-megadyne/ 2017-01-20T00:00:00+00:00 https://biolegacyresearch.com/theranos-last-defender-claims-federal-witch-hunt/ 2017-01-20T00:00:00+00:00 https://biolegacyresearch.com/ovid-release-company-names-m-d-to-scientific-advisory-board/ 2017-01-20T00:00:00+00:00 https://biolegacyresearch.com/nih-director-to-keep-job-under-for-now/ 2017-01-20T00:00:00+00:00 https://biolegacyresearch.com/vanda-release-company-to-announce-fourth-quarter-and-full-year-2016-financial-results-on-february-15-2017/ 2017-01-20T00:00:00+00:00 https://biolegacyresearch.com/a-peek-behind-the-curtain-of-the-ariad-takeda-deal/ 2017-01-20T00:00:00+00:00 https://biolegacyresearch.com/cytosorbents-launches-vetresq-for-u-s-veterinary-market/ 2017-01-20T00:00:00+00:00 https://biolegacyresearch.com/mckesson-pharma-to-pink-slip-some-employees-in-wisconsin-effective-march-31/ 2017-01-20T00:00:00+00:00 https://biolegacyresearch.com/creative-bioarray-release-new-products-of-fish-have-been-released-in-company/ 2017-01-20T00:00:00+00:00 https://biolegacyresearch.com/karolinska-development-ab-release-pharma-portfolio-company-announces-fda-510k-clearance-for-marketing-of-ossdsign-cranial-for-sale-in-the-u-s-a/ 2017-01-20T00:00:00+00:00 https://biolegacyresearch.com/cytovation-release-company-announces-appointment-of-as-scientific-advisor/ 2017-01-20T00:00:00+00:00 https://biolegacyresearch.com/biosig-technologies-release-company-issues-shareholder-letter/ 2017-01-20T00:00:00+00:00 https://biolegacyresearch.com/parexel-release-biopharma-announces-date-of-second-quarter-fiscal-year-2017-earnings-release-and-conference-call/ 2017-01-20T00:00:00+00:00 https://biolegacyresearch.com/fda-cites-22-failed-trials-in-report-making-the-case-for-the-phase-iii-gold-standard/ 2017-01-20T00:04:44+00:00 https://biolegacyresearch.com/ema-backed-the-approval-of-81-drugs-in-2016/ 2017-01-20T00:05:58+00:00 https://biolegacyresearch.com/fda-details-submission-requirements-for-new-regenerative-advanced-therapy-designation/ 2017-01-20T23:58:08+00:00 https://biolegacyresearch.com/new-study-shows-rebates-discounts-growing-when-it-comes-to-pharma-sales/ 2017-01-20T23:59:14+00:00 https://biolegacyresearch.com/cms-no-settlement-yet-to-resolve-mylans-misclassification-of-the-epipen/ 2017-01-21T00:00:12+00:00 https://biolegacyresearch.com/eisai-483-handed-form-483-after-investigators-cite-control-records-capa-procedures/ 2017-01-21T00:01:17+00:00 https://biolegacyresearch.com/regulatory-update/ 2017-01-21T00:02:49+00:00 https://biolegacyresearch.com/world-trade-organization-amends-ip-policy-to-allow-generics-imports-into-poor-nations/ 2017-01-23T23:27:09+00:00 https://biolegacyresearch.com/ftc-strikes-deal-on-pay-for-delay-suit-with-endo-refiles-case-against-allergan/ 2017-01-23T23:27:59+00:00 https://biolegacyresearch.com/merck-settles-patent-dispute-over-keytruda-with-bms-ono-for-625-million-plus-royalties/ 2017-01-23T23:29:02+00:00 https://biolegacyresearch.com/people-on-the-move/ 2017-01-23T23:29:53+00:00 https://biolegacyresearch.com/ich-seeks-to-flesh-out-guidances-on-data-quality-medication-errors-product-issues/ 2017-01-23T23:32:29+00:00 https://biolegacyresearch.com/aslan-release-pharma-to-present-at-the/ 2017-01-24T00:00:00+00:00 https://biolegacyresearch.com/on-a-roll-seattle-genetics-plans-to-hire-200-in-2017/ 2017-01-24T00:00:00+00:00 https://biolegacyresearch.com/quotient-limited-release-company-to-report-third-quarter-fiscal-2017-financial-results-and-host-conference-call/ 2017-01-24T00:00:00+00:00 https://biolegacyresearch.com/merck-co-opens-cambridge-exploratory-science-center-plans-to-hire-30-more-employees/ 2017-01-24T00:00:00+00:00 https://biolegacyresearch.com/bruker-corporation-release-company-announces-acquisition-of-nanoindenting-leader/ 2017-01-24T00:00:00+00:00 https://biolegacyresearch.com/kendall-square-upstart-comes-out-of-stealth-mode-with-26-million/ 2017-01-24T00:00:00+00:00 https://biolegacyresearch.com/bshyftb-analytics-appoints-bjoseph-tyersb-to-chief-revenue-officer/ 2017-01-24T00:00:00+00:00 https://biolegacyresearch.com/why-celgene-should-consider-buying-rival-biogen/ 2017-01-24T00:00:00+00:00 https://biolegacyresearch.com/fujifilm-release-fda-approves-the-companys-digital-breast-tomosynthesis-option-for-aspire-cristalle-digital-mammography-system/ 2017-01-24T00:00:00+00:00 https://biolegacyresearch.com/4-biotechs-to-make-a-move-on-now/ 2017-01-24T00:00:00+00:00 https://biolegacyresearch.com/trump-freezes-fda-hiring-temporarily-halts-new-fda-regulations/ 2017-01-24T00:04:14+00:00 https://biolegacyresearch.com/ema-30-drugs-granted-conditional-market-authorization-in-the-past-decade/ 2017-01-24T23:42:00+00:00 https://biolegacyresearch.com/trumps-pick-to-lead-hhs-says-hes-open-to-better-ways-to-lower-drug-prices/ 2017-01-24T23:42:53+00:00 https://biolegacyresearch.com/uk-looks-toward-investing-in-life-sciences-industry/ 2017-01-24T23:43:00+00:00 https://biolegacyresearch.com/compounding-pharmacy-draws-warning-letter-for-misbranded-unapproved-drugs/ 2017-01-24T23:45:02+00:00 https://biolegacyresearch.com/pfizer-reasserts-claims-against-texas-for-disclosing-medicaid-rebates-to-lawmakers/ 2017-01-24T23:46:00+00:00 https://biolegacyresearch.com/pharma-industry-to-fight-drug-pricing-criticism-with-ad-campaign/ 2017-01-24T23:47:00+00:00 https://biolegacyresearch.com/2-pharmas-set-to-dominate-the-future-of-healthcare/ 2017-01-25T00:00:00+00:00 https://biolegacyresearch.com/biocorp-release-company-to-present-its-innovations-at-on-1st-2nd-february-2017-in-paris/ 2017-01-25T00:00:00+00:00 https://biolegacyresearch.com/the-rise-and-fall-of-cambridge-biotech-startup-gen9/ 2017-01-25T00:00:00+00:00 https://biolegacyresearch.com/akonni-biosystems-release-company-strengthens-leadership-team-with-multiple-key-appointments/ 2017-01-25T00:00:00+00:00 https://biolegacyresearch.com/social-media-rumors-of-juno-acquisition-cause-stock-jitters/ 2017-01-25T00:00:00+00:00 https://biolegacyresearch.com/cambridge-cognition-ltd-release-company-awarded-u-s-regulatory-clearance-for-cantab-mobile/ 2017-01-25T00:00:00+00:00 https://biolegacyresearch.com/bbiopharm-executiveb-is-biotech-getting-away-with-murder/ 2017-01-25T00:00:00+00:00 https://biolegacyresearch.com/etiometry-release-company-reaches-10-million-hours-of-patient-monitoring-data-to-enhance-icu-patient-care/ 2017-01-25T00:00:00+00:00 https://biolegacyresearch.com/watch-out-novartis-ag-hungry-for-small-takeover-targets-with-early-stage-drugs/ 2017-01-25T00:00:00+00:00 https://biolegacyresearch.com/generex-biotechnology-corporation-release-company-welcomes-to-its-board-of-directors/ 2017-01-25T00:00:00+00:00 https://biolegacyresearch.com/fda-rejects-biosimilar-naming-petitions-from-gpha-sandoz-approves-jjs/ 2017-01-25T22:40:00+00:00 https://biolegacyresearch.com/valeant-files-patent-lawsuit-over-zydus-cardizem-generic/ 2017-01-25T22:40:00+00:00 https://biolegacyresearch.com/fda-porton-failed-to-follow-contamination-procedures-notify-agency-of-product-changes/ 2017-01-25T22:40:00+00:00 https://biolegacyresearch.com/mezzion-sues-dr-reddys-for-concealing-gmp-deficiencies-that-resulted-in-an-nda-rejection/ 2017-01-25T22:40:00+00:00 https://biolegacyresearch.com/shredded-documents-and-dirty-equipment-net-hetero-labs-a-form-483/ 2017-01-25T22:40:00+00:00 https://biolegacyresearch.com/its-finally-happening-johnson-johnson-pays-30-billion-for-actelion-will-spin-off-rd-unit-with-1-billion-cash/ 2017-01-26T00:00:00+00:00 https://biolegacyresearch.com/biogen-release-company-reports-2016-revenues-of-11-4-billion/ 2017-01-26T00:00:00+00:00 https://biolegacyresearch.com/celgene-bangs-out-deal-worth-775-million-for-kendall-square-startup-delinia/ 2017-01-26T00:00:00+00:00 https://biolegacyresearch.com/glytec-llc-release-improves-diabetes-care-with-the-companys-eglycemic-management-system/ 2017-01-26T00:00:00+00:00 https://biolegacyresearch.com/this-drug-could-be-johnson-johnsons-next-billion-dollar-blockbuster/ 2017-01-26T00:00:00+00:00 https://biolegacyresearch.com/bsonoma-pharmab-release-company-announces-fiscal-third-quarter-2017-financial-results-and-conference-call/ 2017-01-26T00:00:00+00:00 https://biolegacyresearch.com/incyte-who-why-this-biotech-would-give-gilead-a-bang-for-its-buck/ 2017-01-26T00:00:00+00:00 https://biolegacyresearch.com/bostons-inspire-md-eyes-24-8-million-series-c-round/ 2017-01-26T00:00:00+00:00 https://biolegacyresearch.com/endo-international-eliminates-90-jobs-in-restructuring/ 2017-01-26T00:00:00+00:00 https://biolegacyresearch.com/exact-sciences-to-host-fourth-quarter-full-year-2016-results-webcast-and-call/ 2017-01-26T00:00:00+00:00 https://biolegacyresearch.com/drugmakers-phrma-bio-push-back-against-fda-proposal-for-nonclinical-glps/ 2017-01-26T23:28:21+00:00 https://biolegacyresearch.com/pharma-companies-healthcare-groups-urge-trump-to-support-value-based-care/ 2017-01-26T23:29:19+00:00 https://biolegacyresearch.com/grassley-presses-cms-for-records-answers-on-mylan/ 2017-01-26T23:30:00+00:00 https://biolegacyresearch.com/fda-clarifies-the-relief-gdufa-ii-gives-to-small-businesses/ 2017-01-26T23:31:00+00:00 https://biolegacyresearch.com/biotest-pharma-announces-the-relocation-of-its-plasma-collection-facility-in-gainesville-florida/ 2017-01-27T00:00:00+00:00 https://biolegacyresearch.com/fda-lashes-out-at-jazz-pharma-cmo-for-continued-regulatory-violations/ 2017-01-27T00:00:00+00:00 https://biolegacyresearch.com/qiagen-n-v-s-quantiferon-tb-test-wins-tender-for-testing-of-republic-of-korea-armed-forces-recruits/ 2017-01-27T00:00:00+00:00 https://biolegacyresearch.com/meet-the-29-year-old-man-who-just-launched-biotech-startup/ 2017-01-27T00:00:00+00:00 https://biolegacyresearch.com/immune-pharma-appoints-new-chairman-of-the-board-of-directors/ 2017-01-27T00:00:00+00:00 https://biolegacyresearch.com/ariad-stays-mum-on-layoffs-after-takedas-5-2-billion-takeover/ 2017-01-27T00:00:00+00:00 https://biolegacyresearch.com/xtl-biopharma-announces-ratio-change-of-its-depositary-receipt-program/ 2017-01-27T00:00:00+00:00 https://biolegacyresearch.com/cambridge-biotech-jounce-bounces-on-the-ipo-scene-raises-102-million/ 2017-01-27T00:00:00+00:00 https://biolegacyresearch.com/metabolon-announces-changes-to-executive-leadership-team/ 2017-01-27T00:00:00+00:00 https://biolegacyresearch.com/these-2-new-drugs-make-celgene-an-even-bigger-biotech-powerhouse/ 2017-01-27T00:00:00+00:00 https://biolegacyresearch.com/juno-appoints-as-executive-vice-president-and-head-of-development-operations/ 2017-01-27T00:00:00+00:00 https://biolegacyresearch.com/how-bristol-myers-squibb-went-from-potential-mega-acquirer-to-vulnerable-mega-target/ 2017-01-27T00:00:00+00:00 https://biolegacyresearch.com/neuroderm-announces-extraordinary-general-meeting-of-shareholders/ 2017-01-27T00:00:00+00:00 https://biolegacyresearch.com/meet-the-29-year-old-man-who-just-launched-biotech-startup-advanced-modular-instruments-ami/ 2017-01-27T00:00:00+00:00 https://biolegacyresearch.com/medtronic-snags-coverage-for-micra-leadless-pacer/ 2017-01-27T00:00:00+00:00 https://biolegacyresearch.com/abbvie-reports-full-year-and-fourth-quarter-2016-financial-results/ 2017-01-27T00:00:00+00:00 https://biolegacyresearch.com/fda-postpones-capitol-hill-meetings-on-user-fees-pending-white-house-review/ 2017-01-27T22:43:19+00:00 https://biolegacyresearch.com/ema-committee-recommends-eight-medicines-for-approval/ 2017-01-27T22:44:19+00:00 https://biolegacyresearch.com/court-validates-cumberlands-patent-for-overdose-drug-acetadote-in-dispute-with-mylan/ 2017-01-27T22:45:15+00:00 https://biolegacyresearch.com/teva-unit-settles-cipro-pay-for-delay-case-for-225-million/ 2017-01-27T22:46:00+00:00 https://biolegacyresearch.com/bay-areas-airxpanders-bags-34-million-in-private-placement/ 2017-01-30T00:00:00+00:00 https://biolegacyresearch.com/2-new-names-emerge-as-possible-buyout-candidates-for-ma-hungry-gilead/ 2017-01-30T00:00:00+00:00 https://biolegacyresearch.com/illumina-debuts-veriseq-analysis-software-48-samples-optimized-data-analysis-for-noninvasive-prenatal-testing/ 2017-01-30T00:00:00+00:00 https://biolegacyresearch.com/how-immigration-ban-is-already-hurting-science/ 2017-01-30T00:00:00+00:00 https://biolegacyresearch.com/nuritas-founder-wins-woman-of-the-decade-in-business-and-leadership-award/ 2017-01-30T00:00:00+00:00 https://biolegacyresearch.com/bay-areas-calithera-biosciences-rockets-after-getting-53-million-upfront-in-cancer-deal-with-incyte/ 2017-01-30T00:00:00+00:00 https://biolegacyresearch.com/venbio-calls-on-immunomedics-stockholders-to-support-meaningful-change/ 2017-01-30T00:00:00+00:00 https://biolegacyresearch.com/3-possible-buyout-targets-in-biotech-land/ 2017-01-30T00:00:00+00:00 https://biolegacyresearch.com/agenus-appoints-chief-medical-officer/ 2017-01-30T00:00:00+00:00 https://biolegacyresearch.com/launching-this-week-a-look-at-biogens-spinoff/ 2017-01-30T00:00:00+00:00 https://biolegacyresearch.com/3-things-to-watch-out-in-illuminas-q4/ 2017-01-30T00:00:00+00:00 https://biolegacyresearch.com/trump-orders-agencies-to-repeal-regulations-zero-out-annual-compliance-costs/ 2017-01-30T23:45:19+00:00 https://biolegacyresearch.com/senators-ask-if-fda-will-fill-reviewer-vacancies-despite-trumps-hiring-freeze/ 2017-01-30T23:46:27+00:00 https://biolegacyresearch.com/judge-rules-mylan-infringed-shires-patent-on-ulcerative-colitis-drug-lialda/ 2017-01-30T23:47:34+00:00 https://biolegacyresearch.com/meet-this-largely-over-looked-phase-3-alzheimers-company/ 2017-01-31T00:00:00+00:00 https://biolegacyresearch.com/certara-corporation-releases-new-version-of-d360-its-industry-leading-informatics-platform-for-pharma-discovery-scientists/ 2017-01-31T00:00:00+00:00 https://biolegacyresearch.com/genentechs-oncology-boss-jumps-ship-to-helm-bellicum/ 2017-01-31T00:00:00+00:00 https://biolegacyresearch.com/intralink-spines-rjuve-treatment-nears-completion-of-safety-study-and-begins-multi-site-pivotal-study/ 2017-01-31T00:00:00+00:00 https://biolegacyresearch.com/pfizer-quietly-kills-3-pipeline-programs/ 2017-01-31T00:00:00+00:00 https://biolegacyresearch.com/acorda-to-host-conference-call-to-discuss-fourth-quarter-2016-on-february-14-2017/ 2017-01-31T00:00:00+00:00 https://biolegacyresearch.com/6-biopharma-companies-face-catalysts-in-february/ 2017-01-31T00:00:00+00:00 https://biolegacyresearch.com/bjohn-adamoub-named-vice-president-of-corporate-business-development-at-brhealthb-and-bdna-medicine-instituteb/ 2017-01-31T00:00:00+00:00 https://biolegacyresearch.com/bay-area-biotech-ceos-react-to-s-travel-ban/ 2017-01-31T00:00:00+00:00 https://biolegacyresearch.com/varian-medical-systems-release-treatments-commence-with-varian-truebeam-systems-at-new-london-hospital/ 2017-01-31T00:00:00+00:00 https://biolegacyresearch.com/house-reps-ask-trump-to-clarify-fdas-status-under-hiring-freeze/ 2017-01-31T23:26:00+00:00 https://biolegacyresearch.com/phrma-calls-on-uspto-to-reconsider-patent-eligibility/ 2017-01-31T23:30:00+00:00 https://biolegacyresearch.com/facta-pharmco-cited-by-fda-for-gmp-laboratory-issues/ 2017-01-31T23:34:00+00:00 https://biolegacyresearch.com/api-maker-hit-with-warning-letter-for-inadequate-cleaning-testing-procedures/ 2017-01-31T23:35:00+00:00 https://biolegacyresearch.com/italian-regulator-cites-brazilian-manufacturer-over-data-integrity-quality-management/ 2017-01-31T23:36:42+00:00 https://biolegacyresearch.com/court-strips-teva-of-four-patents-for-ms-drug-copaxone/ 2017-01-31T23:37:48+00:00 https://biolegacyresearch.com/compounder-nets-warning-letter-for-insanitary-cgmp-issues/ 2017-01-31T23:39:00+00:00 https://biolegacyresearch.com/fda-twitter-ad-study-draws-drug-industry-comment/ 2017-01-31T23:41:00+00:00 https://biolegacyresearch.com/amgen-ceo-tells-the-company-plans-to-hire-1600-employees-this-year/ 2017-02-01T00:00:00+00:00 https://biolegacyresearch.com/fda-grants-new-clearance-for-nico-corporations-brain-surgery-technology/ 2017-02-01T00:00:00+00:00 https://biolegacyresearch.com/eli-lilly-washes-its-hands-of-another-phase-3-study-after-the-failure-of-solanezumab/ 2017-02-01T00:00:00+00:00 https://biolegacyresearch.com/abpro-expands-senior-leadership-team-and-announces-adam-mostafa-as-chief-financial-officer/ 2017-02-01T00:00:00+00:00 https://biolegacyresearch.com/bay-areas-galena-biopharma-ceo-steps-down-effective-immediately/ 2017-02-01T00:00:00+00:00 https://biolegacyresearch.com/bmd-logisticsb-release-indiana-3pl-expanding-pharmaceutical-distribution-services/ 2017-02-01T00:00:00+00:00 https://biolegacyresearch.com/as-part-of-digital-industrial-evolution-ge-corporation-lays-off-an-undisclosed-number-of-scientists-in-new-york/ 2017-02-01T00:00:00+00:00 https://biolegacyresearch.com/illumina-reports-full-financial-results-for-fourth-quarter-and-fiscal-year-2016/ 2017-02-01T00:00:00+00:00 https://biolegacyresearch.com/cambridges-dimension-therapeutics-tanks-to-a-new-low-after-revealing-interim-hemophilia-b-data/ 2017-02-01T00:00:00+00:00 https://biolegacyresearch.com/mettler-toledo-presents-a-new-webinar-on-thermometric-titration-of-acid-number/ 2017-02-01T00:00:00+00:00 https://biolegacyresearch.com/eus-envi-committee-approves-report-to-improve-to-drug-access/ 2017-02-01T23:26:26+00:00 https://biolegacyresearch.com/inadequate-controls-faulty-test-methods-lead-to-form-483-for-softech-pharma/ 2017-02-01T23:27:55+00:00 https://biolegacyresearch.com/takeda-to-maintain-drug-pricing-model-after-trump-pressure/ 2017-02-01T23:28:00+00:00 https://biolegacyresearch.com/attention-bay-area-biohub-is-hiring-lots-of-scientists/ 2017-02-02T00:00:00+00:00 https://biolegacyresearch.com/vexim-strengthens-its-intellectual-property-protection-for-the-spinejack-in-asia-two-patents-granted-in-china-and-japan/ 2017-02-02T00:00:00+00:00 https://biolegacyresearch.com/3rd-stemline-patient-died-in-clinical-trial-one-day-before-45-million-public-offering/ 2017-02-02T00:00:00+00:00 https://biolegacyresearch.com/pressure-biosciences-inc-achieves-ce-marking-for-its-next-generation-sample-preparation-instrument-the-barocycler-2320extreme/ 2017-02-02T00:00:00+00:00 https://biolegacyresearch.com/bvividion-therapeuticsb-launches-with-50-million-and-a-celgene-alum-as-executive-chairman/ 2017-02-02T00:00:00+00:00 https://biolegacyresearch.com/anika-therapeutics-to-issue-fourth-quarter-2016-financial-results-and-business-highlights-on-wednesday-february-15/ 2017-02-02T00:00:00+00:00 https://biolegacyresearch.com/why-bay-areas-exelixis-surged-22-in-january/ 2017-02-02T00:00:00+00:00 https://biolegacyresearch.com/5-things-illuminas-management-wants-you-to-know/ 2017-02-02T00:00:00+00:00 https://biolegacyresearch.com/pfizer-turns-to-to-explore-2-billion-sale-of-certain-assets/ 2017-02-02T00:00:00+00:00 https://biolegacyresearch.com/carestream-health-partners-with-shows-imaging-analytics-tools-at-2017/ 2017-02-02T00:00:00+00:00 https://biolegacyresearch.com/fda-civil-monetary-penalties-increase-across-the-board-to-keep-pace-with-inflation/ 2017-02-02T22:47:22+00:00 https://biolegacyresearch.com/ema-publishes-clinical-study-reports-for-two-generics/ 2017-02-02T22:48:17+00:00 https://biolegacyresearch.com/asterias-biotherapeutics-extends-the-expiration-date-of-certain-warrants-and-provides-update-on-cash-position/ 2017-02-03T00:00:00+00:00 https://biolegacyresearch.com/catalyst-biosciences-to-present-at-19th-annual-bio-ceo-investor-conference/ 2017-02-03T00:00:00+00:00 https://biolegacyresearch.com/31-year-old-biotech-guru-brings-in-another-55-million-for-axovant/ 2017-02-03T00:00:00+00:00 https://biolegacyresearch.com/innovia-to-report-fourth-quarter-and-full-year-2016-financial-results-on-february-9-2017-at-500-p-m-est/ 2017-02-03T00:00:00+00:00 https://biolegacyresearch.com/a-look-at-the-types-of-jobs-amgens-promise-to-will-bring/ 2017-02-03T00:00:00+00:00 https://biolegacyresearch.com/lucideon-releases-new-white-paper-on-failure-analysis-of-plastic-products/ 2017-02-03T00:00:00+00:00 https://biolegacyresearch.com/cash-rich-amgen-joins-the-ma-hunt-for-big-and-small-deals/ 2017-02-03T00:00:00+00:00 https://biolegacyresearch.com/orbimed-comments-on-immunomedics-proxy-contest/ 2017-02-03T00:00:00+00:00 https://biolegacyresearch.com/3-biotechs-breathing-down-bristol-myers-squibbs-neck/ 2017-02-03T00:00:00+00:00 https://biolegacyresearch.com/immunovaccine-appoints-seasoned-financial-executive-as-cfo/ 2017-02-03T00:00:00+00:00 https://biolegacyresearch.com/phase-i-clinical-data-of-abx464-abivaxs-first-in-class-anti-hiv-drug-published-in-two-articles-in-peer-reviewed-journals/ 2017-02-03T00:00:00+00:00 https://biolegacyresearch.com/japanese-regulators-approve-s-for-lung-cancer-drug/ 2017-02-03T00:00:00+00:00 https://biolegacyresearch.com/bay-areas-portola-bangs-out-a-150-million-royalty-deal-with/ 2017-02-03T00:00:00+00:00 https://biolegacyresearch.com/envisia-therapeutics-releases-interim-env515-travoprost-xr-phase-ii-data-demonstrating-11-month-duration-of-action-after-a-single-dose-in-patients-with-glaucoma/ 2017-02-03T00:00:00+00:00 https://biolegacyresearch.com/intellipharmaceutics-announces-fda-acceptance-for-filing-of-nda-for-rexista-oxycodone-hydrochloride-extended-release-an-abuse-deterrent-opioid-analgesic-for-the-treatment-of-moderate-to-severe-pain/ 2017-02-03T00:00:00+00:00 https://biolegacyresearch.com/new-jersey-implant-maker-braeburn-pharma-yanks-plans-for-150-million-ipo/ 2017-02-03T00:00:00+00:00 https://biolegacyresearch.com/white-house-clarifies-one-in-two-out-regulations-order/ 2017-02-04T00:04:53+00:00 https://biolegacyresearch.com/fda-to-post-unredacted-advisory-committee-cvs-following-public-citizen-lawsuit/ 2017-02-04T00:05:58+00:00 https://biolegacyresearch.com/spains-aemps-suspends-manufacturing-in-madrid-facility/ 2017-02-04T00:07:08+00:00 https://biolegacyresearch.com/ema-regulatory-guidance-hinders-development-of-atmps/ 2017-02-04T00:08:15+00:00 https://biolegacyresearch.com/federal-government-subpoenas-biogen-over-the-prices-rebates-of-four-therapies/ 2017-02-04T00:09:19+00:00 https://biolegacyresearch.com/ftc-asks-court-to-dismiss-antitrust-claims-against-par-paddock/ 2017-02-04T00:10:31+00:00 https://biolegacyresearch.com/university-of-tubingen-release-neurosciences-a-stress-test-for-men-and-women/ 2017-02-06T00:00:00+00:00 https://biolegacyresearch.com/leica-microsystems-announces-collaboration-with-asm-international/ 2017-02-06T00:00:00+00:00 https://biolegacyresearch.com/pure-bioscience-receives-fda-interim-safety-determination-authorization-to-test-higher-concentrations-of-sdc-based-pure-control-antimicrobial-as-a-poultry-processing-aid/ 2017-02-06T00:00:00+00:00 https://biolegacyresearch.com/thermo-fisher-scientific-release-new-comprehensive-lc-ms-workflow-provides-researchers-with-higher-quality-data-for-clinical-research-samples/ 2017-02-06T00:00:00+00:00 https://biolegacyresearch.com/eli-lilly-seeks-voluntary-exits-from-200-researchers/ 2017-02-06T00:00:00+00:00 https://biolegacyresearch.com/bquantab-appoints-world-leading-nephrologist-to-medical-advisory-board/ 2017-02-06T00:00:00+00:00 https://biolegacyresearch.com/biotech-execs-are-hoping-will-pick-this-man-to-head-the-fda/ 2017-02-06T00:00:00+00:00 https://biolegacyresearch.com/idera-pharma-announces-appointment-of-as-senior-vice-president-of-early-development/ 2017-02-06T00:00:00+00:00 https://biolegacyresearch.com/labcorp-makes-8-billion-proposal-to-cro-ppd/ 2017-02-06T00:00:00+00:00 https://biolegacyresearch.com/obesity-massachusetts-startup-allurion-banks-19-million/ 2017-02-06T00:00:00+00:00 https://biolegacyresearch.com/gottlieb-tops-drugmaker-poll-to-be-next-fda-commissioner/ 2017-02-06T23:21:58+00:00 https://biolegacyresearch.com/lawsuit-endo-allergan-teva-made-pay-for-delay-deal-on-generics/ 2017-02-06T23:22:00+00:00 https://biolegacyresearch.com/spanish-antitrust-authority-investigates-prices-of-aspen-pharmas-cancer-drugs/ 2017-02-06T23:23:55+00:00 https://biolegacyresearch.com/astrazeneca-wins-patent-infringement-suit-over-onglyza-generics-for-diabetes/ 2017-02-06T23:25:05+00:00 https://biolegacyresearch.com/teva-named-in-patent-lawsuit-over-generic-belbuca-challenge/ 2017-02-06T23:26:12+00:00 https://biolegacyresearch.com/catalent-reports-second-quarter-fiscal-year-2017-results/ 2017-02-07T00:00:00+00:00 https://biolegacyresearch.com/genentechs-94000-a-year-drug-tarceva-why-faster-fda-approvals-could-backfire/ 2017-02-07T00:00:00+00:00 https://biolegacyresearch.com/engineers-harness-stomach-acid-to-power-tiny-sensors-mit-study-reveals/ 2017-02-07T00:00:00+00:00 https://biolegacyresearch.com/4-biotech-stocks-worthy-enough-to-be-brokers-favorites/ 2017-02-07T00:00:00+00:00 https://biolegacyresearch.com/berg-announces-appointment-of-as-chief-operating-officer/ 2017-02-07T00:00:00+00:00 https://biolegacyresearch.com/ge-healthcare-to-shutter-maryland-plant-nearly-200-employees-affected/ 2017-02-07T00:00:00+00:00 https://biolegacyresearch.com/bnemaura-pharmab-secures-funding-to-advance-its-micro-patch-solid-dose-microneedle-system-for-a-hormone-biologic/ 2017-02-07T00:00:00+00:00 https://biolegacyresearch.com/merck-kgaa-spinout-prexton-nabs-31-million-to-fund-phase-ii-parkinsons-trials/ 2017-02-07T00:00:00+00:00 https://biolegacyresearch.com/inc-research-schedules-fourth-quarter-and-year-end-2016-earnings-call-for-tuesday-february-28-2017/ 2017-02-07T00:00:00+00:00 https://biolegacyresearch.com/bchris-varmab-co-founder-and-former-president-and-ceo-of-blueprint-medicines-joins-mpm-as-entrepreneur-in-residence/ 2017-02-07T00:00:00+00:00 https://biolegacyresearch.com/160-biotech-leaders-sign-letter-opposing-trumps-immigration-order/ 2017-02-07T23:33:00+00:00 https://biolegacyresearch.com/right-to-try-legislation-finds-support-on-capitol-hill-and-in-the-white-house/ 2017-02-07T23:34:09+00:00 https://biolegacyresearch.com/ftc-complaint-shire-viropharma-filed-baseless-claims-to-block-generic-competition/ 2017-02-07T23:34:55+00:00 https://biolegacyresearch.com/lawmakers-continue-to-press-for-answers-on-implications-of-hiring-freeze-for-fda/ 2017-02-07T23:35:45+00:00 https://biolegacyresearch.com/chaffetz-vows-subpoena-if-mylan-foot-dragging-continues/ 2017-02-07T23:36:00+00:00 https://biolegacyresearch.com/supplement-maker-lands-fda-warning-letter-for-gmp-violations-drug-like-claims/ 2017-02-07T23:37:00+00:00 https://biolegacyresearch.com/bastrazeneca-healthcare-foundationb-awards-more-than-1-75-million-to-10-grassroots-innovative-heart-health-programs/ 2017-02-08T00:00:00+00:00 https://biolegacyresearch.com/out-of-700-applications-puts-47-scientists-under-payroll-in-its-quest-to-cure-all-diseases/ 2017-02-08T00:00:00+00:00 https://biolegacyresearch.com/encision-inc-reports-third-quarter-fiscal-year-2017-results-sequential-quarterly-revenue-grows-4-percent/ 2017-02-08T00:00:00+00:00 https://biolegacyresearch.com/this-could-be-biogens-next-1-billion-blockbuster/ 2017-02-08T00:00:00+00:00 https://biolegacyresearch.com/veracyte-to-expand-patient-access-to-the-afirma-gene-expression-classifier-in-thyroid-cancer-diagnosis-through-agreement-with-quest-diagnostics/ 2017-02-08T00:00:00+00:00 https://biolegacyresearch.com/sinking-teva-needs-a-new-ceo-but-may-need-to-up-salary/ 2017-02-08T00:00:00+00:00 https://biolegacyresearch.com/astellas-names-general-counsel-for-worldwide-legal-organization-and-executive-committee-member/ 2017-02-08T00:00:00+00:00 https://biolegacyresearch.com/fda-to-publicly-disclose-advisory-committee-members-cvs/ 2017-02-08T00:00:00+00:00 https://biolegacyresearch.com/st-jude-medical-discovers-new-cardiac-device-flaws-issues-patch-update/ 2017-02-08T00:00:00+00:00 https://biolegacyresearch.com/heads-up-startups-bayer-ag-is-bringing-its-grants4apps-accelerator-program-to-san-francisco/ 2017-02-08T00:00:00+00:00 https://biolegacyresearch.com/high-court-to-review-180-day-notification-requirement-for-biosimilar/ 2017-02-08T22:18:13+00:00 https://biolegacyresearch.com/wto-amends-ip-policy-to-allow-generics-imports-into-poor-nations/ 2017-02-08T22:20:40+00:00 https://biolegacyresearch.com/merck-settles-patent-dispute-over-keytruda-for-625-m-plus-royalties/ 2017-02-08T22:30:59+00:00 https://biolegacyresearch.com/lilly-prevails-against-tevas-patent-case-maintains-alimta-exclusivity-until-2022/ 2017-02-08T22:33:09+00:00 https://biolegacyresearch.com/president-trump-sued-over-one-in-two-out-executive-order/ 2017-02-08T23:19:02+00:00 https://biolegacyresearch.com/generics-applications-fell-by-about-76-to-57-submissions-lowest-in-9-months/ 2017-02-08T23:20:07+00:00 https://biolegacyresearch.com/jubilant-hollisterstier-receives-form-483-after-inspection-of-canadian-facility/ 2017-02-08T23:20:58+00:00 https://biolegacyresearch.com/ich-announces-new-members-observers/ 2017-02-08T23:22:25+00:00 https://biolegacyresearch.com/promethera-biosciences-s-a-n-v-announces-key-additions-to-its-executive-management-team/ 2017-02-09T00:00:00+00:00 https://biolegacyresearch.com/how-gilead-just-lost-9-billion-in-market-value-this-week/ 2017-02-09T00:00:00+00:00 https://biolegacyresearch.com/breflexion-healthb-to-offer-new-englands-first-in-home-virtual-exercise-rehabilitation-program-at-byale-new-haven-hospitalb/ 2017-02-09T00:00:00+00:00 https://biolegacyresearch.com/acorda-rockets-after-parkinsons-drug-hits-late-stage-goals/ 2017-02-09T00:00:00+00:00 https://biolegacyresearch.com/israeli-medtech-startup-raises-8-million/ 2017-02-09T00:00:00+00:00 https://biolegacyresearch.com/this-20-employee-kendall-square-biotech-just-secured-a-seat-on-upcoming-space-rocket/ 2017-02-09T00:00:00+00:00 https://biolegacyresearch.com/surmodics-announces-2017-annual-shareholders-meeting/ 2017-02-09T00:00:00+00:00 https://biolegacyresearch.com/reckitt-benckiser-to-lay-off-140-employees-in-missouri/ 2017-02-09T00:00:00+00:00 https://biolegacyresearch.com/syndax-appoints-as-chief-financial-officer/ 2017-02-09T00:00:00+00:00 https://biolegacyresearch.com/reunited-and-it-feels-so-good-after-the-success-of-serial-biotech-duo-launches/ 2017-02-09T00:00:00+00:00 https://biolegacyresearch.com/hhs-exempts-fda-medical-officer-positions-and-more-from-hiring-freeze/ 2017-02-09T23:15:51+00:00 https://biolegacyresearch.com/senators-request-details-on-kaleos-pricing-model-for-overdose-drug-evzio/ 2017-02-09T23:17:17+00:00 https://biolegacyresearch.com/sanofi-regeneron-allowed-to-sell-cholesterol-drug-pending-an-appeal-on-injunction/ 2017-02-09T23:19:31+00:00 https://biolegacyresearch.com/nuvasive-reports-fourth-quarter-and-full-year-2016-financial-results/ 2017-02-10T00:00:00+00:00 https://biolegacyresearch.com/daiichi-sankyo-shutters-yet-another-rd-facility/ 2017-02-10T00:00:00+00:00 https://biolegacyresearch.com/diagnostic-lab-on-a-chip-produced-for-mere-penny-stanford-university-school-of-medicine-reveals/ 2017-02-10T00:00:00+00:00 https://biolegacyresearch.com/seattle-genetics-immunomedics-ink-2-billion-tumor-drug-deal/ 2017-02-10T00:00:00+00:00 https://biolegacyresearch.com/internationally-renowned-city-of-hope-scientist-ph-d-named-chair-in-diabetes-drug-discovery/ 2017-02-10T00:00:00+00:00 https://biolegacyresearch.com/sarepta-under-pressure-as-marathon-pharma-emflazas-wins-fda-approval-for-dmd/ 2017-02-10T00:00:00+00:00 https://biolegacyresearch.com/sentreheart-announces-positive-reimbursement-renewal-decision-in-germany/ 2017-02-10T00:00:00+00:00 https://biolegacyresearch.com/aurobindo-eyes-u-s-plant-in-new-jersey-as-calls-for-local-drug-production/ 2017-02-10T00:00:00+00:00 https://biolegacyresearch.com/taro-provides-results-for-december-31-2016/ 2017-02-10T00:00:00+00:00 https://biolegacyresearch.com/3-biotech-stocks-able-to-weather-an-unstable-administration/ 2017-02-10T00:00:00+00:00 https://biolegacyresearch.com/why-intercept-pharma-stock-jumped-nearly-10-on-friday-after-providing-phase-iii-update/ 2017-02-10T00:00:00+00:00 https://biolegacyresearch.com/greiner-bio-one-inc-launches-new-innovative-celldisc-product-for-mass-cell-culture/ 2017-02-10T00:00:00+00:00 https://biolegacyresearch.com/vaxil-biotherapeutics-to-present-at-bio-ceo-investor-conference-february-13-14-2017/ 2017-02-10T00:00:00+00:00 https://biolegacyresearch.com/epinex-diagnostics-to-present-at-the-bio-ceo-investor-conference/ 2017-02-10T00:00:00+00:00 https://biolegacyresearch.com/fda-dhs-warn-of-cyber-vulnerabilities-in-st-jude-cardiac-devices/ 2017-02-10T22:03:33+00:00 https://biolegacyresearch.com/cfda-issues-guidance-on-quality-control-product-inspection/ 2017-02-10T22:04:39+00:00 https://biolegacyresearch.com/zimmer-biomet-hit-with-58-page-form-483-citing-14-observations/ 2017-02-10T22:06:19+00:00 https://biolegacyresearch.com/nomax-lands-warning-letter-for-documentation-other-violations/ 2017-02-10T22:07:13+00:00 https://biolegacyresearch.com/covidien-gets-form-483-for-design-installation-problems/ 2017-02-10T22:08:15+00:00 https://biolegacyresearch.com/fda-reclassifies-influenza-test-systems-as-class-ii/ 2017-02-10T22:09:45+00:00 https://biolegacyresearch.com/best-medical-canada-lands-form-483-for-complaint-procedures/ 2017-02-10T22:11:01+00:00 https://biolegacyresearch.com/becton-dickinson-caribe-gets-form-483-for-process-validation/ 2017-02-10T22:11:53+00:00 https://biolegacyresearch.com/risk-rankings-can-help-manage-suppliers-expert-says/ 2017-02-10T22:13:06+00:00 https://biolegacyresearch.com/price-set-to-begin-work-repealing-aca-cutting-costs/ 2017-02-10T23:29:02+00:00 https://biolegacyresearch.com/grassley-planning-to-investigate-orphan-designations-impact-on-high-drug-prices/ 2017-02-10T23:30:02+00:00 https://biolegacyresearch.com/doj-seeks-to-intervene-in-multistate-antitrust-suit-against-6-generics-makers/ 2017-02-10T23:30:57+00:00 https://biolegacyresearch.com/court-revives-antitrust-suit-against-takeda/ 2017-02-10T23:31:45+00:00 https://biolegacyresearch.com/regeneron-joins-string-of-pharma-companies-subpoenaed-over-pricing-programs/ 2017-02-10T23:33:42+00:00 https://biolegacyresearch.com/ema-sees-28-percent-increase-in-orphan-drug-applications-in-2016/ 2017-02-10T23:35:04+00:00 https://biolegacyresearch.com/essa-pharma-provides-business-update-and-announces-financial-results-for-the-first-quarter-ended-december-31-2016/ 2017-02-13T00:00:00+00:00 https://biolegacyresearch.com/bioanalytical-systems-inc-to-release-first-quarter-fiscal-2017-results-on-tuesday-february-14-2017/ 2017-02-13T00:00:00+00:00 https://biolegacyresearch.com/why-immunomedics-2-billion-deal-with-seattle-genetics-has-venbio-ticked-off-and-red-faced/ 2017-02-13T00:00:00+00:00 https://biolegacyresearch.com/new-technique-allows-study-of-micronutrient-dynamics-in-human-3d-minibrains-reveals/ 2017-02-13T00:00:00+00:00 https://biolegacyresearch.com/this-is-how-47-scientists-were-selected-for-the-chan-zuckerberg-biohub/ 2017-02-13T00:00:00+00:00 https://biolegacyresearch.com/all-signs-have-gilead-gearing-up-for-a-much-needed-acquisition/ 2017-02-13T00:00:00+00:00 https://biolegacyresearch.com/brprd-diagnosticsb-announces-strategic-collaboration-with-bchildrens-minnesotab-to-advance-clinical-pharmacogenomics/ 2017-02-13T00:00:00+00:00 https://biolegacyresearch.com/2-biotechs-taking-on-the-20-billion-alzheimers-market-full-force/ 2017-02-13T00:00:00+00:00 https://biolegacyresearch.com/bendeceb-opens-san-francisco-office/ 2017-02-13T00:00:00+00:00 https://biolegacyresearch.com/deal-spree-continues-as-allergan-inks-2-47-billion-deal-for-this-bay-area-biotech/ 2017-02-13T00:00:00+00:00 https://biolegacyresearch.com/data-integrity-lab-control-issues-lead-to-483s-for-two-manufacturers/ 2017-02-13T00:05:16+00:00 https://biolegacyresearch.com/fda-porton-failed-to-follow-contamination-procedures/ 2017-02-13T00:06:37+00:00 https://biolegacyresearch.com/italian-regulator-cites-brazilian-manufacturer-over-quality-management/ 2017-02-13T00:10:26+00:00 https://biolegacyresearch.com/japanese-drugmaker-eisai-handed-483-due-to-data-integrity-quality-concerns/ 2017-02-13T00:11:27+00:00 https://biolegacyresearch.com/compounder-draws-warning-letter-for-misbranded-unapproved-drugs/ 2017-02-13T00:12:26+00:00 https://biolegacyresearch.com/merck-sharp-dohme-chibret-draws-form-483-for-sterilization-failures/ 2017-02-13T00:14:05+00:00 https://biolegacyresearch.com/api-maker-handed-form-483-after-failed-lab-controls-and-repeat-observations/ 2017-02-13T00:15:00+00:00 https://biolegacyresearch.com/mckesson-to-pay-record-fine-for-not-reporting-suspicious-opioid-orders/ 2017-02-13T00:16:28+00:00 https://biolegacyresearch.com/sanders-cummings-launch-congressional-investigation-into-marathons-89000-drug/ 2017-02-13T23:27:02+00:00 https://biolegacyresearch.com/appeals-court-reverses-infringement-ruling-on-shires-lialda-patent-in-win-for-actavis/ 2017-02-13T23:27:55+00:00 https://biolegacyresearch.com/sandoz-to-supreme-court-circuit-erred-in-ruling-180-day-notification-required-after-biosimilar-approval/ 2017-02-13T23:29:34+00:00 https://biolegacyresearch.com/sponsors-request-more-bioequivalence-details-in-ema-guideline-on-multi-region-clinical-trials/ 2017-02-13T23:31:27+00:00 https://biolegacyresearch.com/ema-proposes-clarification-to-anti-cancer-drug-guidance-ambiguities/ 2017-02-13T23:32:17+00:00 https://biolegacyresearch.com/ema-publishes-1000th-post-marketing-study-in-online-registry/ 2017-02-13T23:33:23+00:00 https://biolegacyresearch.com/bristol-myers-squibb-could-finally-go-on-the-market-rumored-suitors-include-gilead-pfizer-novartis-ag-and-roche/ 2017-02-14T00:00:00+00:00 https://biolegacyresearch.com/misonix-reports-receipt-of-deficiency-letter-from-the/ 2017-02-14T00:00:00+00:00 https://biolegacyresearch.com/why-secretive-5-billion-biotech-moderna-may-not-be-able-to-commercialize-products-into-clinical-trials/ 2017-02-14T00:00:00+00:00 https://biolegacyresearch.com/iradimed-corporation-poised-for-market-domination/ 2017-02-14T00:00:00+00:00 https://biolegacyresearch.com/pfizer-quietly-takes-16-4-stake-in-this-socal-medtech-firm/ 2017-02-14T00:00:00+00:00 https://biolegacyresearch.com/teewinot-life-sciences-announces-breakthrough-commercial-production-of-the-cannabinoid-varin-series/ 2017-02-14T00:00:00+00:00 https://biolegacyresearch.com/former-celgene-and-medtronic-ceos-just-acquired-this-maryland-biotech/ 2017-02-14T00:00:00+00:00 https://biolegacyresearch.com/quintilesims-reports-fourth-quarter-and-full-year-2016-results-issues-first-quarter-and-full-year-2017-guidance/ 2017-02-14T00:00:00+00:00 https://biolegacyresearch.com/roche-faces-off-with-itself-for-9-billion-breast-cancer-drug-business/ 2017-02-14T00:00:00+00:00 https://biolegacyresearch.com/first-databank-inc-launches-fdb-prizm-medical-device-knowledge-platform/ 2017-02-14T00:00:00+00:00 https://biolegacyresearch.com/fda-adds-scenarios-to-gmp-guidance-on-combo-products/ 2017-02-14T22:25:27+00:00 https://biolegacyresearch.com/fda-outlines-studies-required-for-new-drugs-with-potential-for-abuse/ 2017-02-14T22:25:51+00:00 https://biolegacyresearch.com/ich-to-augment-guidances-on-data-quality-product-issues/ 2017-02-14T22:26:19+00:00 https://biolegacyresearch.com/ema-inadequate-guidance-hinders-atmp-approvals/ 2017-02-14T22:27:34+00:00 https://biolegacyresearch.com/spanish-authority-investigates-prices-of-aspen-pharmas-cancer-drugs/ 2017-02-14T22:28:01+00:00 https://biolegacyresearch.com/italian-regulator-cites-brazilian-manufacturer-over-data-integrity/ 2017-02-14T22:28:30+00:00 https://biolegacyresearch.com/ema-30-drugs-granted-conditional-approval-in-past-decade/ 2017-02-14T22:29:00+00:00 https://biolegacyresearch.com/danish-medicines-agency-issues-gmp-non-compliance-report/ 2017-02-14T22:29:32+00:00 https://biolegacyresearch.com/three-senators-urge-hhs-to-allow-importing-drugs-from-canada-to-cut-costs/ 2017-02-14T23:32:47+00:00 https://biolegacyresearch.com/ema-clarifies-approach-to-pharmacovigilance-fees-in-revised-qa-guidance/ 2017-02-14T23:33:40+00:00 https://biolegacyresearch.com/phrma-delivers-report-on-global-patent-barriers-to-u-s-trade-representative/ 2017-02-14T23:34:30+00:00 https://biolegacyresearch.com/novartis-generics-industry-criticize-fda-for-underestimating-burden-of-random-suffixes-for-biologics/ 2017-02-14T23:35:23+00:00 https://biolegacyresearch.com/ema-met-performance-targets-saw-increase-in-inspection-requests-in-first-half-of-2016/ 2017-02-14T23:36:13+00:00 https://biolegacyresearch.com/fda-cites-facilities-in-china-japan-and-india/ 2017-02-14T23:37:00+00:00 https://biolegacyresearch.com/questions-remain-over-suicide-death-of-genentech-lobbyist/ 2017-02-15T00:00:00+00:00 https://biolegacyresearch.com/biontech-release-mammatyper-enables-more-precise-prediction-of-the-response-to-neoadjuvant-chemotherapy-compared-to-manual-or-digitalized-ihc/ 2017-02-15T00:00:00+00:00 https://biolegacyresearch.com/another-drug-bites-the-dust-merck-co-stops-late-stage-alzheimers-study/ 2017-02-15T00:00:00+00:00 https://biolegacyresearch.com/charleston-laboratories-announces-senior-global-regulatory-hire/ 2017-02-15T00:00:00+00:00 https://biolegacyresearch.com/bay-area-biotech-launches-with-33-million-and-could-double-its-headcount-by-next-year/ 2017-02-15T00:00:00+00:00 https://biolegacyresearch.com/medovex-corporation-completes-phase-ii-ce-mark-audit-with-notified-body-lnegmed/ 2017-02-15T00:00:00+00:00 https://biolegacyresearch.com/gilead-announces-144-week-data-evaluating-safety-and-efficacy-of-genvoya-for-treatment-of-hiv-1-in-treatment-nave-adults/ 2017-02-15T00:00:00+00:00 https://biolegacyresearch.com/united-therapeutics-to-report-fourth-quarter-and-annual-2016-financial-results-before-the-market-opens-on-wednesday-february-22-2017/ 2017-02-15T00:00:00+00:00 https://biolegacyresearch.com/new-socal-biotech-makes-debut-and-will-take-on-nash/ 2017-02-15T00:00:00+00:00 https://biolegacyresearch.com/is-there-a-silver-lining-for-fitbit/ 2017-02-15T00:00:00+00:00 https://biolegacyresearch.com/gao-downgrades-rating-of-fdas-action-plans-for-postmarket-drug-monitoring-and-shortages/ 2017-02-15T23:38:38+00:00 https://biolegacyresearch.com/expert-discusses-major-shifts-to-look-for-under-cures-act/ 2017-02-15T23:40:35+00:00 https://biolegacyresearch.com/china-to-reform-oversight-of-drug-prices-gmp-compliance/ 2017-02-15T23:41:49+00:00 https://biolegacyresearch.com/pfizer-flynn-appeal-uk-fine-over-excessive-price-of-anti-epilepsy-phenytoin-sodium-capsules/ 2017-02-15T23:42:46+00:00 https://biolegacyresearch.com/fda-publishes-clinical-trials-demographics-from-67-novel-drug-approvals/ 2017-02-15T23:44:05+00:00 https://biolegacyresearch.com/glytec-llc-release-new-research-further-validates-benefits-of-personalized-diabetes-therapy-management-across-the-continuum-of-care/ 2017-02-16T00:00:00+00:00 https://biolegacyresearch.com/3-biotechs-with-the-biggest-and-most-promising-pipelines/ 2017-02-16T00:00:00+00:00 https://biolegacyresearch.com/therapeuticsmd-announces-webcast-of-investor-day-on-march-1/ 2017-02-16T00:00:00+00:00 https://biolegacyresearch.com/here-are-5-tricky-job-interview-questions-you-might-get-at-genentech-regeneron-and-stratos/ 2017-02-16T00:00:00+00:00 https://biolegacyresearch.com/syndax-to-announce-fourth-quarter-and-year-end-2016-financial-results-and-host-conference-call-and-webcast-on-march-2-2017/ 2017-02-16T00:00:00+00:00 https://biolegacyresearch.com/first-ariad-now-puts-this-drug-company-on-notice/ 2017-02-16T00:00:00+00:00 https://biolegacyresearch.com/glaukos-completes-patient-enrollment-in-pivotal-phase-of-u-s-ide-clinical-trial-for-istent-supra/ 2017-02-16T00:00:00+00:00 https://biolegacyresearch.com/bristol-myers-squibb-may-be-on-the-market-but-pfizer-probably-wont-bite/ 2017-02-16T00:00:00+00:00 https://biolegacyresearch.com/icon-reports-fourth-quarter-and-full-year-2016-results/ 2017-02-16T00:00:00+00:00 https://biolegacyresearch.com/how-to-write-the-best-cover-letter-for-a-research-scientist-job/ 2017-02-16T00:00:00+00:00 https://biolegacyresearch.com/editors-note/ 2017-02-16T23:27:33+00:00 https://biolegacyresearch.com/verma-negotiating-medicare-drug-prices-not-a-simple-yes-or-no-answer/ 2017-02-16T23:28:00+00:00 https://biolegacyresearch.com/celgene-settles-patent-royalty-case-for-198-5-million/ 2017-02-16T23:30:12+00:00 https://biolegacyresearch.com/court-rules-generics-makers-infringed-latuda-aloxi-patents/ 2017-02-16T23:32:34+00:00 https://biolegacyresearch.com/ctti-publishes-recommendations-for-pediatric-clinical-trials-of-antibiotics/ 2017-02-16T23:34:01+00:00 https://biolegacyresearch.com/the-medicines-company-to-announce-fourth-quarter-and-full-year-2016-financial-results-on-february-28-2017/ 2017-02-17T00:00:00+00:00 https://biolegacyresearch.com/4-biopharma-stocks-a-billionaire-investor-just-bought/ 2017-02-17T00:00:00+00:00 https://biolegacyresearch.com/bprotonicsb-t2-exo-strength-speed-agility-pain/ 2017-02-17T00:00:00+00:00 https://biolegacyresearch.com/woman-to-watch-meet-the-woman-who-is-helming-bostons-cocoon-biotech/ 2017-02-17T00:00:00+00:00 https://biolegacyresearch.com/medtronic-announces-japanese-regulatory-approval-for-micra-transcatheter-pacing-system-tps/ 2017-02-17T00:00:00+00:00 https://biolegacyresearch.com/sage-therapeutics-boss-gets-overenthusiastic-about-drug-walks-back-discussion-of-ma-activity/ 2017-02-17T00:00:00+00:00 https://biolegacyresearch.com/macrogenics-announces-date-of-fourth-quarter-and-full-year-2016-financial-results-conference-call/ 2017-02-17T00:00:00+00:00 https://biolegacyresearch.com/after-merck-co-eli-lilly-alzheimers-failures-a-look-at-7-companies-still-on-the-hunt/ 2017-02-17T00:00:00+00:00 https://biolegacyresearch.com/zika-testing-mistakes-require-re-testing-of-over-400-specimens/ 2017-02-17T00:00:00+00:00 https://biolegacyresearch.com/astrazeneca-plc-investors-pumped-as-breast-cancer-drug-sails-through-phase-iii-trial/ 2017-02-17T00:00:00+00:00 https://biolegacyresearch.com/how-much-money-embattled-theranos-has-left-in-the-bank/ 2017-02-17T00:00:00+00:00 https://biolegacyresearch.com/a-novel-quantitative-immunohistochemistry-method-enabled-by-biogenex-inc-ihc-system/ 2017-02-17T00:00:00+00:00 https://biolegacyresearch.com/fda-clears-expanded-indication-for-medtronics-freezor-xtra-cryoablation-catheter/ 2017-02-17T00:00:00+00:00 https://biolegacyresearch.com/prolung-announces-the-appointment-of-to-its-board-of-directors/ 2017-02-17T00:00:00+00:00 https://biolegacyresearch.com/maetrics-launches-new-training-courses-for-2017/ 2017-02-17T00:00:00+00:00 https://biolegacyresearch.com/university-at-albany-release-biochemists-technique-rapidly-detects-ebola-virus/ 2017-02-17T00:00:00+00:00 https://biolegacyresearch.com/tga-looks-to-replace-burdensome-requirements-for-distributing-unapproved-drugs/ 2017-02-17T23:46:43+00:00 https://biolegacyresearch.com/fda-cites-two-api-makers-for-data-and-label-discrepancies/ 2017-02-17T23:47:39+00:00 https://biolegacyresearch.com/the-10-biggest-losers-in-biopharma-last-year/ 2017-02-20T00:00:00+00:00 https://biolegacyresearch.com/bvoxellob-snags-fda-nod-for-noddle-speech-generation-device/ 2017-02-20T00:00:00+00:00 https://biolegacyresearch.com/this-drug-could-rattle-biogen-and-be-the-next-billion-dollar-blockbuster-for-celgene/ 2017-02-20T00:00:00+00:00 https://biolegacyresearch.com/bjoe-ryanb-joins-bbit-groupb-as-vice-president-business-development/ 2017-02-20T00:00:00+00:00 https://biolegacyresearch.com/meet-the-professor-who-was-the-first-to-question-theranos-research/ 2017-02-20T00:00:00+00:00 https://biolegacyresearch.com/sysmex-americato-distribute-erythrocyte-sedimentation-rate-products-from-alifax-s-p-a/ 2017-02-20T00:00:00+00:00 https://biolegacyresearch.com/heres-where-jobs-in-shrinking-life-sciences-marketing-departments-are-headed/ 2017-02-20T00:00:00+00:00 https://biolegacyresearch.com/abbvie-declares-quarterly-dividend/ 2017-02-20T00:00:00+00:00 https://biolegacyresearch.com/norwegian-biotech-upstart-has-become-a-potential-takeover-target/ 2017-02-20T00:00:00+00:00 https://biolegacyresearch.com/novel-material-made-of-living-cells-glows-when-touching-certain-chemical-compounds-mit-study-reveals/ 2017-02-20T00:00:00+00:00 https://biolegacyresearch.com/eagle-pharma-announces-new-patents-issued-for-bendeka/ 2017-02-21T00:00:00+00:00 https://biolegacyresearch.com/rumored-acquisition-target-bristol-myers-squibb-names-3-new-directors-plans-2-billion-accelerated-share-buyback/ 2017-02-21T00:00:00+00:00 https://biolegacyresearch.com/select-medical-announces-appointment-of-to-the-board-of-directors/ 2017-02-21T00:00:00+00:00 https://biolegacyresearch.com/this-tiny-biotech-grew-412-in-2016-a-look-at-whether-it-can-continue-in-2017/ 2017-02-21T00:00:00+00:00 https://biolegacyresearch.com/kindred-bio-to-announce-fourth-quarter-and-year-end-2016-financial-results/ 2017-02-21T00:00:00+00:00 https://biolegacyresearch.com/pfizer-continues-190-million-expansion-plans-in-north-carolina/ 2017-02-21T00:00:00+00:00 https://biolegacyresearch.com/nordson-pounce-buy-pieces-of-vention-medical/ 2017-02-21T00:00:00+00:00 https://biolegacyresearch.com/zoning-changes-kills-sale-of-bristol-myers-squibbs-connecticut-campus/ 2017-02-21T00:00:00+00:00 https://biolegacyresearch.com/bbiotalent-canadab-release-new-report-newcomers-to-canada-need-ways-to-show-skills-to-biotech-employers/ 2017-02-21T00:00:00+00:00 https://biolegacyresearch.com/sarepta-auctions-off-its-priority-review-voucher-for-exondys-51-to-gilead-for-125-million/ 2017-02-21T00:00:00+00:00 https://biolegacyresearch.com/gilead-obtains-third-priority-review-voucher-from-sarepta-for-125-million/ 2017-02-21T23:20:00+00:00 https://biolegacyresearch.com/biosimilars-council-statute-does-not-grant-extra-six-month-exclusivity-for-biologics/ 2017-02-21T23:21:00+00:00 https://biolegacyresearch.com/drugmaker-humco-lands-warning-letter-over-gmp-deficiencies-unapproved-drugs/ 2017-02-21T23:22:00+00:00 https://biolegacyresearch.com/emas-gcp-working-group-outlines-inspection-priorities-planned-guidances/ 2017-02-21T23:23:00+00:00 https://biolegacyresearch.com/icardiac-technologies-unveils-an-innovative-and-highly-customizable-ecoa-platform/ 2017-02-22T00:00:00+00:00 https://biolegacyresearch.com/these-are-the-4-most-admired-life-science-companies-in-the-world/ 2017-02-22T00:00:00+00:00 https://biolegacyresearch.com/prolacta-bioscience-to-present-at-the-2017-conference-on-february-22-2017/ 2017-02-22T00:00:00+00:00 https://biolegacyresearch.com/serial-investor-takes-stake-in-bristol-myers-squibb-stock-jumps/ 2017-02-22T00:00:00+00:00 https://biolegacyresearch.com/pdl-biopharma-to-announce-fourth-quarter-year-end-2016-financial-results-on-march-1-2017/ 2017-02-22T00:00:00+00:00 https://biolegacyresearch.com/massachusetts-agenus-quietly-discloses-failure-of-cancer-vaccine-trial/ 2017-02-22T00:00:00+00:00 https://biolegacyresearch.com/henry-schein-announces-exclusive-distribution-agreement-for-s-cardiosleeve/ 2017-02-22T00:00:00+00:00 https://biolegacyresearch.com/bbiopharm-executiveb-biotech-is-it-time-to-secede/ 2017-02-22T00:00:00+00:00 https://biolegacyresearch.com/healthsouth-reports-strong-revenue-and-earnings-growth-for-fourth-quarter-2016-and-reiterates-full-year-2017-guidance/ 2017-02-22T00:00:00+00:00 https://biolegacyresearch.com/north-korean-biotech-institute-allegedly-involved-in-the-killing-of-leader-half-brother/ 2017-02-22T00:00:00+00:00 https://biolegacyresearch.com/drugmakers-ask-for-choice-between-product-and-site-quality-metric-reports/ 2017-02-22T22:49:31+00:00 https://biolegacyresearch.com/phrma-ceo-links-press-coverage-of-high-prices-and-the-need-for-generic-competition/ 2017-02-22T22:50:18+00:00 https://biolegacyresearch.com/louisiana-company-ordered-to-cease-operations-for-selling-unapproved-drugs-and-supplements/ 2017-02-22T22:51:16+00:00 https://biolegacyresearch.com/acro-urges-fda-to-include-e-consent-in-ich-pediatric-clinical-trials-guideline/ 2017-02-22T22:52:07+00:00 https://biolegacyresearch.com/ema-considers-using-big-data-and-real-world-evidence-in-approval-decisions/ 2017-02-22T22:52:57+00:00 https://biolegacyresearch.com/india-proposes-risk-based-pre-inspections-among-fixes-to-address-substandard-drugs/ 2017-02-22T23:05:53+00:00 https://biolegacyresearch.com/sage-therapeutics-announces-fourth-quarter-and-full-year-2016-financial-results-and-provides-corporate-update/ 2017-02-23T00:00:00+00:00 https://biolegacyresearch.com/future-biotech-giants-11-life-science-entrepreneurs-under-30/ 2017-02-23T00:00:00+00:00 https://biolegacyresearch.com/presbia-announces-extension-of-rights-offering/ 2017-02-23T00:00:00+00:00 https://biolegacyresearch.com/roche-reports-death-in-phase-iii-hemophilia-study/ 2017-02-23T00:00:00+00:00 https://biolegacyresearch.com/fda-approves-seventh-sense-biosystems-first-ever-device-for-fast-and-virtually-painless-blood-draw/ 2017-02-23T00:00:00+00:00 https://biolegacyresearch.com/serial-biotech-entrepreneur-to-helm-biotech-startup-after-retiring-from-harvard/ 2017-02-23T00:00:00+00:00 https://biolegacyresearch.com/bbluechiip-ltdb-half-yearly-report-and-accounts/ 2017-02-23T00:00:00+00:00 https://biolegacyresearch.com/the-worlds-richest-doctors-new-cancer-vaccine-and-nantkwests-science/ 2017-02-23T00:00:00+00:00 https://biolegacyresearch.com/ifm-therapeutics-appoints-renowned-physicians-from-academia-and-industry-to-clinical-advisory-board/ 2017-02-23T00:00:00+00:00 https://biolegacyresearch.com/2-biotechs-that-had-a-rough-2016-but-may-be-poised-for-a-turnaround-this-year/ 2017-02-23T00:00:00+00:00 https://biolegacyresearch.com/xenex-locks-in-38-million-in-funding/ 2017-02-24T00:00:00+00:00 https://biolegacyresearch.com/surprising-departure-celgene-president-and-coo-retiring-in-the-summer/ 2017-02-24T00:00:00+00:00 https://biolegacyresearch.com/otonomy-to-report-fourth-quarter-and-full-year-2016-financial-results-and-provide-corporate-update/ 2017-02-24T00:00:00+00:00 https://biolegacyresearch.com/bayers-job-cuts-at-mission-bay-campus-leaves-room-for-new-bay-area-startups/ 2017-02-24T00:00:00+00:00 https://biolegacyresearch.com/instantlabs-secures-controlling-investment-from/ 2017-02-24T00:00:00+00:00 https://biolegacyresearch.com/50-valeant-sales-reps-may-have-jumped-ship-to-synergy-pharma/ 2017-02-24T00:00:00+00:00 https://biolegacyresearch.com/medivirs-nomination-committee-proposes-new-board-of-directors-ahead-of-2017-agm/ 2017-02-24T00:00:00+00:00 https://biolegacyresearch.com/buyers-remorse-merck-co-takes-2-9-billion-charge-on-hepatitis-c-drug-inherited-from-3-9-billion-idenix-buy/ 2017-02-24T00:00:00+00:00 https://biolegacyresearch.com/volitionrxs-triage-test-results-validated-in-prospective-trial/ 2017-02-24T00:00:00+00:00 https://biolegacyresearch.com/investors-breathe-a-sigh-of-relief-cempras-skin-infection-drug-hits-phase-iii-goals/ 2017-02-24T00:00:00+00:00 https://biolegacyresearch.com/ohr-pharma-suspends-work-at-san-diego-lab/ 2017-02-24T00:00:00+00:00 https://biolegacyresearch.com/ovascience-to-host-fourth-quarter-and-fiscal-year-2016-financial-results-conference-call/ 2017-02-24T00:00:00+00:00 https://biolegacyresearch.com/monaghan-medical-s-drug-free-aerobika-device-helps-reduce-the-real-world-impact-of-exacerbations-in-chronic-obstructive-pulmonary-disease/ 2017-02-24T00:00:00+00:00 https://biolegacyresearch.com/achaogen-announces-leadership-promotions/ 2017-02-24T00:00:00+00:00 https://biolegacyresearch.com/medtronic-receives-ce-mark-for-its-next-generation-cardiac-resynchronization-therapy-pacemakers/ 2017-02-24T00:00:00+00:00 https://biolegacyresearch.com/bio-rad-reports-fourth-quarter-and-full-year-2016-financial-results/ 2017-02-24T00:00:00+00:00 https://biolegacyresearch.com/maryland-considers-laws-requiring-drugmakers-to-justify-price-increases-and-publish-cost-data/ 2017-02-24T00:00:44+00:00 https://biolegacyresearch.com/supreme-court-restricts-scope-of-patent-infringement-on-exported-components/ 2017-02-24T00:01:45+00:00 https://biolegacyresearch.com/china-revises-list-of-reimbursed-drugs-adds-over-300-therapies/ 2017-02-24T00:03:02+00:00 https://biolegacyresearch.com/solicitor-general-generics-makers-rally-behind-sandoz-in-biosimilar-case/ 2017-02-24T23:02:53+00:00 https://biolegacyresearch.com/fda-ordered-to-create-a-new-regulatory-task-force/ 2017-02-24T23:04:22+00:00 https://biolegacyresearch.com/fda-cites-sovereign-pharmaceuticals-for-building-failures-unwritten-procedures/ 2017-02-24T23:05:24+00:00 https://biolegacyresearch.com/emas-chmp-gives-nod-to-six-drugs-in-the-eu/ 2017-02-24T23:06:18+00:00 https://biolegacyresearch.com/cel-sci-announces-that-the-nyse-mkt-approves-plan/ 2017-02-27T00:00:00+00:00 https://biolegacyresearch.com/brainstorm-cell-names-and-to-its-board-of-directors-as-company-prepares-for-clinical-and-commercial-success/ 2017-02-27T00:00:00+00:00 https://biolegacyresearch.com/6-biotechs-set-up-shop-and-create-jobs-in-buffalo-new-york/ 2017-02-27T00:00:00+00:00 https://biolegacyresearch.com/biotech-vets-launch-with-38-million-and-will-be-helmed-by-biogen-alum/ 2017-02-27T00:00:00+00:00 https://biolegacyresearch.com/new-study-assesses-the-utility-of-masimo-pvi-monitoring-during-colorectal-surgery/ 2017-02-27T00:00:00+00:00 https://biolegacyresearch.com/dechra-releases-its-2017-half-yearly-financial-report/ 2017-02-27T00:00:00+00:00 https://biolegacyresearch.com/6-biotechs-facing-key-fda-decisions-in-march/ 2017-02-27T00:00:00+00:00 https://biolegacyresearch.com/crisprcas9-startup-launches-in-boston/ 2017-02-27T00:00:00+00:00 https://biolegacyresearch.com/medtronic-evp-rtg-president-to-speak-at-cowen-and-company-healthcare-conference/ 2017-02-27T00:00:00+00:00 https://biolegacyresearch.com/a-look-inside-takedas-remarkable-rd-transformation/ 2017-02-27T00:00:00+00:00 https://biolegacyresearch.com/pfizer-subpoenaed-by-u-s-attorney-over-cost-cutting-programs-for-drugs/ 2017-02-27T22:49:12+00:00 https://biolegacyresearch.com/california-introduces-bill-to-prohibit-prescription-drug-coupons/ 2017-02-27T22:50:22+00:00 https://biolegacyresearch.com/eli-lilly-merck-pfizer-and-celgene-ceos-back-republican-led-tax-reform/ 2017-02-27T22:51:16+00:00 https://biolegacyresearch.com/tax-court-mylan-must-deliver-licensing-agreement-docs-to-the-irs/ 2017-02-27T22:53:03+00:00 https://biolegacyresearch.com/exelixis-announces-fourth-quarter-and-full-year-2016-financial-results-and-provides-corporate-update/ 2017-02-28T00:00:00+00:00 https://biolegacyresearch.com/perrigo-cuts-750-jobs-sells-ms-drug-royalties-for-2-85-billion-and-loses-cfo-to-amgen/ 2017-02-28T00:00:00+00:00 https://biolegacyresearch.com/former-allergan-chief-signs-on-as-special-advisor-to-sienna-biopharma/ 2017-02-28T00:00:00+00:00 https://biolegacyresearch.com/troubled-cempra-slashes-67-of-workforce/ 2017-02-28T00:00:00+00:00 https://biolegacyresearch.com/proqr-therapeutics-b-v-announces-results-for-the-fourth-quarter-and-full-year-2016-and-provides-a-business-update/ 2017-02-28T00:00:00+00:00 https://biolegacyresearch.com/momenta-to-become-neighbors-with-biogen-ironwood-in-kendall-square-next-year/ 2017-02-28T00:00:00+00:00 https://biolegacyresearch.com/new-method-for-integrating-flexible-electronics-into-skin-patches-reveals/ 2017-02-28T00:00:00+00:00 https://biolegacyresearch.com/pieris-surged-on-82-75-million-anemia-drug-deal/ 2017-02-28T00:00:00+00:00 https://biolegacyresearch.com/medpace-reports-fourth-quarter-and-full-year-2016-results/ 2017-02-28T00:00:00+00:00 https://biolegacyresearch.com/bgatesb-backed-cambridge-startup-affinivax-grabs-10-million-deal-with-japanese-drug-giant-astellas/ 2017-02-28T00:00:00+00:00 https://biolegacyresearch.com/fda-cites-pfizer-over-contaminated-vials-at-hospira-facility-in-kansas/ 2017-02-28T23:13:09+00:00 https://biolegacyresearch.com/democrats-try-again-on-drug-importation/ 2017-02-28T23:14:00+00:00 https://biolegacyresearch.com/who-releases-draft-update-of-stability-testing-guidelines/ 2017-02-28T23:14:53+00:00 https://biolegacyresearch.com/drugmakers-side-with-regeneron-sanofi-in-patent-case-over-amgens-repatha/ 2017-02-28T23:15:58+00:00 https://biolegacyresearch.com/chinese-api-maker-cited-over-data-integrity-in-fda-warning-letter/ 2017-02-28T23:16:45+00:00 https://biolegacyresearch.com/thermo-fisher-scientific-declares-quarterly-dividend/ 2017-03-01T00:00:00+00:00 https://biolegacyresearch.com/bpresident-trumpb-keep-your-bpeterb-bthielb-out-of-our-fda-politics/ 2017-03-01T00:00:00+00:00 https://biolegacyresearch.com/bphosphorusb-announces-formation-of-scientific-advisory-board/ 2017-03-01T00:00:00+00:00 https://biolegacyresearch.com/avoid-these-3-biotech-stocks-like-the-plague/ 2017-03-01T00:00:00+00:00 https://biolegacyresearch.com/halozyme-reports-fourth-quarter-and-full-year-2016-financial-results/ 2017-03-01T00:00:00+00:00 https://biolegacyresearch.com/hygieia-completes-acquisition-of-global-food-safety-diagnostics-business-from-dupont/ 2017-03-01T00:00:00+00:00 https://biolegacyresearch.com/novartis-ag-puts-cancer-hopes-on-4-star-scientists-poached-from-harvard-last-year/ 2017-03-01T00:00:00+00:00 https://biolegacyresearch.com/acceleron-pharma-reports-fourth-quarter-and-year-ended-2016-operational-and-financial-results/ 2017-03-01T00:00:00+00:00 https://biolegacyresearch.com/veloxis-pharma-to-shut-down-new-jersey-office-moving-all-operations-to-north-carolina/ 2017-03-01T00:00:00+00:00 https://biolegacyresearch.com/fda-release-mutual-recognition-promises-new-framework-for-pharmaceutical-inspections-for-united-states-and-european-union/ 2017-03-02T00:00:00+00:00 https://biolegacyresearch.com/backed-by-amazon-and-big-names-like-bristol-myers-squibb-celgene-and-merck-co-bay-areas-grail-banks-900-million/ 2017-03-02T00:00:00+00:00 https://biolegacyresearch.com/paratek-pharma-reports-full-year-and-fourth-quarter-2016-financial-results-and-provides-clinical-update/ 2017-03-02T00:00:00+00:00 https://biolegacyresearch.com/scientists-heres-the-best-elevator-pitch-to-sell-yourself-to-a-potential-employer/ 2017-03-02T00:00:00+00:00 https://biolegacyresearch.com/cryoport-to-report-financial-results-for-the-three-and-nine-months-ended-december-31-2016-on-march-13th-2017/ 2017-03-02T00:00:00+00:00 https://biolegacyresearch.com/juno-finally-drops-problem-car-t-drug-that-caused-deaths/ 2017-03-02T00:00:00+00:00 https://biolegacyresearch.com/ace-laboratories-appoints-inaugural-scientific-and-clinical-advisory-board/ 2017-03-02T00:00:00+00:00 https://biolegacyresearch.com/arix-bioscience-takeda-partner-up-to-create-and-grow-biotechs/ 2017-03-02T00:00:00+00:00 https://biolegacyresearch.com/alimera-sciences-reports-record-fourth-quarter-and-full-year-2016-financial-results/ 2017-03-02T00:00:00+00:00 https://biolegacyresearch.com/genentech-new-breast-cancer-cocktail-cuts-deaths-in-phase-iii-study-roche-stock-soars/ 2017-03-02T00:00:00+00:00 https://biolegacyresearch.com/trump-targets-fda-approval-process-in-first-speech-to-congress/ 2017-03-02T00:10:49+00:00 https://biolegacyresearch.com/white-house-planning-to-cut-non-defense-spending-by-54-billion/ 2017-03-02T00:11:52+00:00 https://biolegacyresearch.com/group-of-international-generics-regulators-releases-template-for-biowaiver-assessment/ 2017-03-02T00:12:56+00:00 https://biolegacyresearch.com/price-growth-of-orphan-drugs-slows-as-market-continues-to-grow/ 2017-03-02T00:13:58+00:00 https://biolegacyresearch.com/chinese-firm-cited-for-recordkeeping-violations-inadequate-testing/ 2017-03-02T00:15:02+00:00 https://biolegacyresearch.com/judge-dismisses-genentechs-lawsuit-accusing-amgen-of-withholding-biosimilar-info/ 2017-03-02T23:41:40+00:00 https://biolegacyresearch.com/fda-proposes-eight-month-review-of-priority-generics-plans-for-wave-of-biosimilars/ 2017-03-02T23:42:31+00:00 https://biolegacyresearch.com/dermira-presents-new-data-in-primary-axillary-hyperhidrosis-and-acne-at-american-academy-of-dermatology-2017-annual-meeting/ 2017-03-03T00:00:00+00:00 https://biolegacyresearch.com/filings-reveal-billionaire-super-investor-stocked-up-on-these-2-biotech-stocks/ 2017-03-03T00:00:00+00:00 https://biolegacyresearch.com/fda-grants-orphan-drug-designation-to-prometics-pbi-4050-drug-for-the-treatment-of-alstrm-syndrome/ 2017-03-03T00:00:00+00:00 https://biolegacyresearch.com/rumor-alert-novartis-ag-in-talks-to-buy-nash-biotech-genfit/ 2017-03-03T00:00:00+00:00 https://biolegacyresearch.com/sartorius-pays-320-million-cash-to-take-out-essen-bioscience/ 2017-03-03T00:00:00+00:00 https://biolegacyresearch.com/orbimed-to-raise-450-million-for-third-asia-life-science-fund/ 2017-03-03T00:00:00+00:00 https://biolegacyresearch.com/aeterna-zentaris-announces-presentation-regarding-macrilen-at-99th-annual-meeting-of/ 2017-03-03T00:00:00+00:00 https://biolegacyresearch.com/following-up-on-bristol-myers-squibbs-restructuring-plans-company-makes-move-to-shift-1250-workers-out-of-hopewell-township-site/ 2017-03-03T00:00:00+00:00 https://biolegacyresearch.com/chinese-billionaires-biotech-hutchison-china-meditech-chi-med-shows-off-phase-iii-cancer-drug-data/ 2017-03-03T00:00:00+00:00 https://biolegacyresearch.com/sanofi-pasteur-inks-645-million-rsv-deal-with-astrazeneca-plcs-medimmune/ 2017-03-03T00:00:00+00:00 https://biolegacyresearch.com/9-massachusetts-biotechs-facing-major-fda-decisions-this-year/ 2017-03-03T00:00:00+00:00 https://biolegacyresearch.com/bekg-labsb-expands-analytical-laboratory-for-medical-device-and-pharmaceutical-services/ 2017-03-03T00:00:00+00:00 https://biolegacyresearch.com/edwards-lifesciences-gets-split-decision-in-uk-heart-valve-patent-spat-with-boston-scientific/ 2017-03-03T00:00:00+00:00 https://biolegacyresearch.com/cohbar-to-announce-fourth-quarter-2016-financial-results-and-host-conference-call-for-shareholders-on-march-22-2017/ 2017-03-03T00:00:00+00:00 https://biolegacyresearch.com/inc-research-appoints-and-to-board-of-directors/ 2017-03-03T00:00:00+00:00 https://biolegacyresearch.com/staar-surgical-reports-fourth-quarter-2016-results/ 2017-03-03T00:00:00+00:00 https://biolegacyresearch.com/u-s-e-u-agree-on-mutual-recognition-of-drug-manufacturing-inspections/ 2017-03-03T00:21:00+00:00 https://biolegacyresearch.com/gao-drugmakers-say-unclear-fda-guidance-hinders-antibiotics-development/ 2017-03-03T00:22:46+00:00 https://biolegacyresearch.com/ec-report-recommends-policy-actions-on-off-label-use/ 2017-03-03T23:44:55+00:00 https://biolegacyresearch.com/uk-antitrust-regulator-accuses-actavis-concordia-of-delaying-competition-to-fix-prices/ 2017-03-03T23:45:44+00:00 https://biolegacyresearch.com/20-states-join-antitrust-lawsuit-accusing-6-generics-makers-of-price-collusion/ 2017-03-03T23:46:33+00:00 https://biolegacyresearch.com/ftc-seeks-dismissal-of-watson-allergan-claims-on-limited-scope-of-authority/ 2017-03-03T23:47:35+00:00 https://biolegacyresearch.com/navidea-completes-sale-of-north-american-rights-of-lymphoseek-to-cardinal-health/ 2017-03-06T00:00:00+00:00 https://biolegacyresearch.com/coo-and-first-employee-of-editas-medicine-to-exit-effective-march-31/ 2017-03-06T00:00:00+00:00 https://biolegacyresearch.com/aeterna-zentaris-to-announce-fourth-quarter-and-full-year-2016-financial-and-operating-results-on-march-15-2017/ 2017-03-06T00:00:00+00:00 https://biolegacyresearch.com/why-this-alzheimers-biotech-may-not-live-to-see-2020/ 2017-03-06T00:00:00+00:00 https://biolegacyresearch.com/provectus-announces-extension-of-rights-offering-due-to-receipt-of-unsolicited-investment-proposals-to-invest-in/ 2017-03-06T00:00:00+00:00 https://biolegacyresearch.com/biotech-gurus-roivant-sciences-could-soon-double-its-headcount-in-north-carolina/ 2017-03-06T00:00:00+00:00 https://biolegacyresearch.com/applied-stemcell-inc-announces-the-appointment-of-dr-stanford-professor-and-vice-president-of-to-its-sab/ 2017-03-06T00:00:00+00:00 https://biolegacyresearch.com/2-tempting-biotech-stocks-to-avoid-like-mad/ 2017-03-06T00:00:00+00:00 https://biolegacyresearch.com/pierre-fabre-and-announce-a-strategic-commercial-partnership-for-tolak-fluorouracil-cream-4-in-the-usa-and-beyond/ 2017-03-06T00:00:00+00:00 https://biolegacyresearch.com/the-elephant-in-the-room-investors-pushing-for-lower-pay-for-1st-female-glaxosmithkline-ceo/ 2017-03-06T00:00:00+00:00 https://biolegacyresearch.com/senators-launch-investigations-on-orphan-drugs/ 2017-03-06T23:20:07+00:00 https://biolegacyresearch.com/pics-hits-european-commission-over-relaxed-atmp-gmps/ 2017-03-06T23:31:41+00:00 https://biolegacyresearch.com/samsung-bioepis-prevails-in-uk-patent-court-dispute-over-abbvies-humira/ 2017-03-06T23:32:35+00:00 https://biolegacyresearch.com/fda-places-clinical-hold-on-scynexis-iv-antifungal-lifts-hold-on-seattle-genetics-aml-treatment/ 2017-03-06T23:33:23+00:00 https://biolegacyresearch.com/innoviva-files-preliminary-proxy-materials-for-2017-annual-meeting/ 2017-03-07T00:00:00+00:00 https://biolegacyresearch.com/third-rock-ventures-quietly-launches-in-editas-medicines-hq/ 2017-03-07T00:00:00+00:00 https://biolegacyresearch.com/4-critical-takeaways-from-3d-systems-q4-earnings-call/ 2017-03-07T00:00:00+00:00 https://biolegacyresearch.com/bpresident-trumpb-tosses-tweet-bomb-at-drug-industry-stocks-drop/ 2017-03-07T00:00:00+00:00 https://biolegacyresearch.com/immunocellular-therapeutics-to-report-fourth-quarter-and-full-year-2016-financial-results-on-march-9-2017/ 2017-03-07T00:00:00+00:00 https://biolegacyresearch.com/meet-man-in-the-lab-at-the/ 2017-03-07T00:00:00+00:00 https://biolegacyresearch.com/brhealthb-announces-ongoing-collaboration-with-bioverativ/ 2017-03-07T00:00:00+00:00 https://biolegacyresearch.com/worlds-richest-doctor-accused-of-diverting-donations-back-to-his-own-companies/ 2017-03-07T00:00:00+00:00 https://biolegacyresearch.com/arena-to-provide-corporate-update-and-release-fourth-quarter-and-full-year-2016-financial-results-on-tuesday-march-14-2017/ 2017-03-07T00:00:00+00:00 https://biolegacyresearch.com/why-pharma-giant-astrazeneca-plcs-market-value-gained-3-8-billion-last-month/ 2017-03-07T00:00:00+00:00 https://biolegacyresearch.com/cardiac-science-cited-over-purchasing-data/ 2017-03-07T22:27:51+00:00 https://biolegacyresearch.com/savaria-concord-lifts-cited-for-capa-procedures/ 2017-03-07T22:28:40+00:00 https://biolegacyresearch.com/microport-orthopedics-notes-ceramic-head-manufacturing-defect/ 2017-03-07T22:29:58+00:00 https://biolegacyresearch.com/fda-form-483-dings-x-zeal-on-design-validation-reporting-procedures/ 2017-03-07T22:30:47+00:00 https://biolegacyresearch.com/mhra-issues-guidance-on-infections-from-heater-cooler-units/ 2017-03-07T22:31:37+00:00 https://biolegacyresearch.com/koreas-neo-vision-gets-warning-letter-for-design-controls/ 2017-03-07T22:32:00+00:00 https://biolegacyresearch.com/biotronik-gets-warning-letter-for-validation-other-procedures/ 2017-03-07T22:33:17+00:00 https://biolegacyresearch.com/india-overhauls-medical-device-regulations/ 2017-03-07T22:34:10+00:00 https://biolegacyresearch.com/flotec-cited-for-nonconforming-product-procedures/ 2017-03-07T22:35:03+00:00 https://biolegacyresearch.com/inovar-targeted-for-inadequate-product-certification/ 2017-03-07T22:35:46+00:00 https://biolegacyresearch.com/woodcock-plans-to-revamp-nda-program-infrastructure/ 2017-03-07T23:23:43+00:00 https://biolegacyresearch.com/trump-working-on-new-system-to-bring-down-drug-prices/ 2017-03-07T23:25:29+00:00 https://biolegacyresearch.com/south-korea-fines-novartis-suspends-products-over-kickback-case/ 2017-03-07T23:26:13+00:00 https://biolegacyresearch.com/australian-tga-reports-increased-inspections-in-2016/ 2017-03-07T23:27:04+00:00 https://biolegacyresearch.com/fda-updates-policies-for-its-controlled-substances-reviewers/ 2017-03-07T23:27:55+00:00 https://biolegacyresearch.com/acerus-reports-fourth-quarter-and-full-year-2016-financial-results/ 2017-03-08T00:00:00+00:00 https://biolegacyresearch.com/former-and-forum-pharma-ceo-resurfaces-to-helm-massachusetts-biotech/ 2017-03-08T00:00:00+00:00 https://biolegacyresearch.com/ultrafast-detection-of-a-cancer-biomarker-enabled-by-innovative-nanobiodevice-reveals/ 2017-03-08T00:00:00+00:00 https://biolegacyresearch.com/boscarb-winner-turned-pharma-ceo-well-prevent-genital-herpes/ 2017-03-08T00:00:00+00:00 https://biolegacyresearch.com/index-pharmaceuticals-ab-appoints-new-cfo/ 2017-03-08T00:00:00+00:00 https://biolegacyresearch.com/3-little-known-biotechs-that-could-double-overnight/ 2017-03-08T00:00:00+00:00 https://biolegacyresearch.com/almac-diagnostics-and-eortc-establish-collaboration-for-tumor-molecular-profiling/ 2017-03-08T00:00:00+00:00 https://biolegacyresearch.com/pfizer-eyes-100-million-expansion-new-jobs-in-north-carolina/ 2017-03-08T00:00:00+00:00 https://biolegacyresearch.com/kura-oncology-to-report-fourth-quarter-and-full-year-2016-financial-results/ 2017-03-08T00:00:00+00:00 https://biolegacyresearch.com/backed-by-google-cambridges-spero-nabs-51-7-million-series-c/ 2017-03-08T00:00:00+00:00 https://biolegacyresearch.com/democratic-reps-discuss-medicare-price-negotiation-with-an-enthusiastic-president/ 2017-03-08T23:49:38+00:00 https://biolegacyresearch.com/fda-finds-another-wockhardt-facility-out-of-compliance/ 2017-03-08T23:50:31+00:00 https://biolegacyresearch.com/fda-hits-api-manufacturer-with-warning-letter-for-gmp-data-integrity-problems/ 2017-03-08T23:51:33+00:00 https://biolegacyresearch.com/arch-pharmalabs-cited-for-water-quality-computer-problems/ 2017-03-08T23:52:45+00:00 https://biolegacyresearch.com/pharming-group-report-on-preliminary-financial-results-for-2016/ 2017-03-09T00:00:00+00:00 https://biolegacyresearch.com/retrophin-to-close-down-cambridge-operations-cut-jobs-in-consolidation-move/ 2017-03-09T00:00:00+00:00 https://biolegacyresearch.com/edwards-lifesciences-corporation-release-german-patent-court-issues-initial-decision/ 2017-03-09T00:00:00+00:00 https://biolegacyresearch.com/this-bay-area-biotech-is-being-wooed-by-drug-giant-novo-nordisk-as/ 2017-03-09T00:00:00+00:00 https://biolegacyresearch.com/3-ways-fitbit-stock-can-double-from-here/ 2017-03-09T00:00:00+00:00 https://biolegacyresearch.com/9-questionable-drugs-biotechs-are-submitting-to-the-fda-in-a-hail-mary-pass/ 2017-03-09T00:00:00+00:00 https://biolegacyresearch.com/agile-therapeutics-inc-reports-fourth-quarter-and-full-year-2016-financial-results/ 2017-03-09T00:00:00+00:00 https://biolegacyresearch.com/3-biotechs-under-5-with-jaw-dropping-growth-potential/ 2017-03-09T00:00:00+00:00 https://biolegacyresearch.com/basi-names-senior-vice-president-of-preclinical-services/ 2017-03-09T00:00:00+00:00 https://biolegacyresearch.com/merck-kgaa-in-deep-talks-to-sell-biosimilars-unit/ 2017-03-09T00:00:00+00:00 https://biolegacyresearch.com/petition-calls-on-fda-to-set-timeline-for-designation-appeals-process/ 2017-03-09T23:24:19+00:00 https://biolegacyresearch.com/india-again-requests-trial-protocols-from-combo-drug-manufacturers/ 2017-03-09T23:25:03+00:00 https://biolegacyresearch.com/amneal-pharmaceuticals-cited-for-tardy-submissions/ 2017-03-09T23:25:49+00:00 https://biolegacyresearch.com/semler-scientific-reports-fourth-quarter-and-annual-2016-financial-results/ 2017-03-10T00:00:00+00:00 https://biolegacyresearch.com/why-this-biotech-has-amazon-growth-potential/ 2017-03-10T00:00:00+00:00 https://biolegacyresearch.com/boc-sciencess-new-services-antibody-drug-conjugates-service/ 2017-03-10T00:00:00+00:00 https://biolegacyresearch.com/a-win-for-venbio-as-judge-hits-pause-on-immunomedicss-2-billion-deal-with-seattle-genetics/ 2017-03-10T00:00:00+00:00 https://biolegacyresearch.com/afraxis-inc-announces-new-imagedirect-sm-analysis-service/ 2017-03-10T00:00:00+00:00 https://biolegacyresearch.com/argos-cuts-staff-by-38-after-devastating-phase-iii-news/ 2017-03-10T00:00:00+00:00 https://biolegacyresearch.com/bristol-myers-squibb-to-announce-results-for-first-quarter-2017-on-april-27/ 2017-03-10T00:00:00+00:00 https://biolegacyresearch.com/boston-scientific-commits-to-10-more-years-in-socal-space-plans-to-hire/ 2017-03-10T00:00:00+00:00 https://biolegacyresearch.com/optimized-sensors-to-study-learning-and-memory-study/ 2017-03-10T00:00:00+00:00 https://biolegacyresearch.com/bay-areas-galena-biopharma-exploring-strategic-alternatives-just-one-month-after-ceo-steps-down/ 2017-03-10T00:00:00+00:00 https://biolegacyresearch.com/omeros-to-announce-fourth-quarter-and-year-end-2016-financial-results-on-march-16-2017/ 2017-03-10T00:00:00+00:00 https://biolegacyresearch.com/rosalind-franklin-university-of-medicine-and-science-announces-construction-of-new-innovation-and-research-park/ 2017-03-10T00:00:00+00:00 https://biolegacyresearch.com/why-an-acquisition-of-this-car-t-biotech-makes-sense/ 2017-03-10T00:00:00+00:00 https://biolegacyresearch.com/autonomic-tech-announces-expanded-indication-in-europe-ce-mark-for-disabling-migraine-with-pulsante-spg-microstimulator-system/ 2017-03-10T00:00:00+00:00 https://biolegacyresearch.com/amphastar-to-release-fourth-quarter-earnings-and-hold-conference-call-on-march-13-2017/ 2017-03-10T00:00:00+00:00 https://biolegacyresearch.com/bone-therapeutics-to-participate-in-upcoming-key-investor-conferences/ 2017-03-10T00:00:00+00:00 https://biolegacyresearch.com/trump-to-nominate-scott-gottlieb-for-fda-commissioner/ 2017-03-10T23:42:43+00:00 https://biolegacyresearch.com/phrma-lilly-urge-hhs-to-create-new-safe-harbors-for-value-based-payments-pbm-fees/ 2017-03-10T23:44:26+00:00 https://biolegacyresearch.com/approvals-for-505b2-drugs-slower-than-for-nmes-report-says/ 2017-03-10T23:44:55+00:00 https://biolegacyresearch.com/fda-partially-grants-petition-on-generic-opioid-testing/ 2017-03-10T23:46:04+00:00 https://biolegacyresearch.com/generic-drug-approvals-see-slight-uptick-in-february/ 2017-03-10T23:46:32+00:00 https://biolegacyresearch.com/could-this-be-the-biggest-biotech-breakthrough-of-the-decade/ 2017-03-13T00:00:00+00:00 https://biolegacyresearch.com/fda-demands-karyopharm-stop-enrollment-of-all-selinexor-trials/ 2017-03-13T00:00:00+00:00 https://biolegacyresearch.com/dexcom-appoints-to-board-of-directors/ 2017-03-13T00:00:00+00:00 https://biolegacyresearch.com/shakeup-at-intrexon-as-a-subsidiary-is-created-and-an-ex-pfizer-exec-exits-in-reorg/ 2017-03-13T00:00:00+00:00 https://biolegacyresearch.com/biotime-expands-opregen-clinical-trial-in-dry-amd-with-opening-of-first-u-s-sites/ 2017-03-13T00:00:00+00:00 https://biolegacyresearch.com/tesaro-announces-niraparib-data-presentations-at-the-2017-annual-meeting-on-womens-cancer/ 2017-03-13T00:00:00+00:00 https://biolegacyresearch.com/marinus-pharma-provides-business-update-and-2016-financial-results/ 2017-03-13T00:00:00+00:00 https://biolegacyresearch.com/zenosense-mids-quantitative-testing-results/ 2017-03-13T00:00:00+00:00 https://biolegacyresearch.com/rumors-surface-ma-desperate-gilead-is-nearing-a-deal-to-buy-incyte/ 2017-03-13T00:00:00+00:00 https://biolegacyresearch.com/fda-demands-karyopharm-stop-enrollment-of-all-selinexor-trials/ 2017-03-13T00:00:00+00:00 https://biolegacyresearch.com/gottlieb-nomination-draws-positive-reviews-and-some-questions/ 2017-03-13T21:25:00+00:00 https://biolegacyresearch.com/fda-mulls-establishing-patient-affairs-office-to-support-drug-development/ 2017-03-13T21:27:00+00:00 https://biolegacyresearch.com/dr-reddys-hit-with-form-483-for-records-testing-issues/ 2017-03-13T21:38:00+00:00 https://biolegacyresearch.com/fda-targets-infar-over-testing-records-sanitation/ 2017-03-13T21:56:00+00:00 https://biolegacyresearch.com/amphastar-reports-financial-results-for-the-three-months-and-fiscal-year-ended-december-31-2016/ 2017-03-14T00:00:00+00:00 https://biolegacyresearch.com/2-biotechs-that-could-vanish-by-2019/ 2017-03-14T00:00:00+00:00 https://biolegacyresearch.com/teleflex-inc-wins-fda-approval-of-its-twin-pass-torque-dual-access-catheter/ 2017-03-14T00:00:00+00:00 https://biolegacyresearch.com/bbernie-sandersb-btrumpb-must-stop-sanofis-exclusive-zika-deal/ 2017-03-14T00:00:00+00:00 https://biolegacyresearch.com/nativis-inc-convenes-inaugural-ultra-low-radio-frequency-energy-technology-advisory-board-tab-meeting/ 2017-03-14T00:00:00+00:00 https://biolegacyresearch.com/what-a-gilead-incyte-marriage-would-look-like/ 2017-03-14T00:00:00+00:00 https://biolegacyresearch.com/roche-launches-the-cobas-egfr-mutation-test-v2-for-use-with-either-plasma-or-tumor-tissue-samples/ 2017-03-14T00:00:00+00:00 https://biolegacyresearch.com/3-dazzling-biotechs-poised-to-soar-even-more/ 2017-03-14T00:00:00+00:00 https://biolegacyresearch.com/peregrine-reports-financial-results-for-the-third-quarter-of-fiscal-year-2017-and-recent-developments/ 2017-03-14T00:00:00+00:00 https://biolegacyresearch.com/backmanb-is-finally-done-with-valeant-takes-2-8-billion-loss-and-will-step-down-from-board/ 2017-03-14T00:00:00+00:00 https://biolegacyresearch.com/pfizers-hospira-draws-warning-letter-for-quality-defects/ 2017-03-14T20:45:52+00:00 https://biolegacyresearch.com/louisiana-company-ordered-to-cease-operations-for-gmp-violations/ 2017-03-14T20:47:08+00:00 https://biolegacyresearch.com/fda-clarifies-ich-guideline-on-drug-starting-materials/ 2017-03-14T20:48:41+00:00 https://biolegacyresearch.com/fda-targets-facilities-in-china-india/ 2017-03-14T20:49:40+00:00 https://biolegacyresearch.com/china-to-reform-oversight-of-gmp-compliance/ 2017-03-14T20:50:38+00:00 https://biolegacyresearch.com/india-proposes-pre-inspections-to-find-substandard-drugs/ 2017-03-14T20:57:54+00:00 https://biolegacyresearch.com/fda-advisory-committees-say-opana-er-benefits-no-longer-outweigh-risks/ 2017-03-14T21:49:01+00:00 https://biolegacyresearch.com/amgen-to-supreme-court-180-day-notification-for-biosimilar-launch-must-come-after-fda-approval/ 2017-03-14T21:50:15+00:00 https://biolegacyresearch.com/patent-office-affirms-four-of-acordas-patents-on-ms-drug-ampyra-pending-court-ruling/ 2017-03-14T21:52:00+00:00 https://biolegacyresearch.com/mylan-settles-with-roche-genentech-clearing-path-for-herceptin-biosimilar/ 2017-03-14T21:54:14+00:00 https://biolegacyresearch.com/fda-hits-two-api-firms-with-warning-letters-for-data-integrity-misbranding/ 2017-03-14T21:56:10+00:00 https://biolegacyresearch.com/bclarivate-analyticsb-launches-new-product-suite-reducing-risk-and-saving-time-for-researchers-selecting-next-drug-target/ 2017-03-15T00:00:00+00:00 https://biolegacyresearch.com/worlds-smartest-billionaire-upped-position-in-this-bay-area-biotech/ 2017-03-15T00:00:00+00:00 https://biolegacyresearch.com/boston-biomedical-associates-to-present-at-the-2017-outsourcing-in-clinical-trials-israel-conference-in-march/ 2017-03-15T00:00:00+00:00 https://biolegacyresearch.com/despite-expansion-overall-roche-diabetes-care-lays-off-157/ 2017-03-15T00:00:00+00:00 https://biolegacyresearch.com/infinity-pharma-provides-company-update-and-reports-fourth-quarter-2016-financial-results/ 2017-03-15T00:00:00+00:00 https://biolegacyresearch.com/ex-google-rock-star-decides-to-raise-100-million-biotech-venture-fund-after-all/ 2017-03-15T00:00:00+00:00 https://biolegacyresearch.com/bnovigenixb-signs-distribution-agreement-with-bdr-risch-medical-laboratoryb-to-access-swiss-german-market-for-colox-its-blood-based-colorectal-cancer-test/ 2017-03-15T00:00:00+00:00 https://biolegacyresearch.com/why-pfizer-will-not-make-another-mega-ma-deal-anytime-soon/ 2017-03-15T00:00:00+00:00 https://biolegacyresearch.com/reminder-centene-corporations-2017-first-quarter-financial-results-conference-call/ 2017-03-15T00:00:00+00:00 https://biolegacyresearch.com/actelions-rd-discovery-biz-gets-a-name/ 2017-03-15T00:00:00+00:00 https://biolegacyresearch.com/20-states-join-suit-accusing-6-generics-makers-of-price-fixing/ 2017-03-15T21:18:08+00:00 https://biolegacyresearch.com/generics-regulators-release-template-for-biowaiver-assessment/ 2017-03-15T21:19:15+00:00 https://biolegacyresearch.com/appeals-court-reverses-infringement-ruling-on-shires-lialda-patent/ 2017-03-15T21:25:44+00:00 https://biolegacyresearch.com/gao-downgrades-rating-of-fdas-action-plans-for-postmarket-monitoring/ 2017-03-15T21:43:54+00:00 https://biolegacyresearch.com/ftc-shire-viropharma-filed-baseless-claims-to-block-generics/ 2017-03-15T21:47:44+00:00 https://biolegacyresearch.com/fda-committee-suggests-flexible-approach-to-qualifying-data/ 2017-03-15T22:57:50+00:00 https://biolegacyresearch.com/house-ec-committee-leaders-seek-additional-info-on-fdas-heparin-investigations/ 2017-03-15T22:58:47+00:00 https://biolegacyresearch.com/abpi-rebukes-four-drugmakers-for-breaching-code-of-practice/ 2017-03-15T23:00:59+00:00 https://biolegacyresearch.com/fda-warns-supplement-maker-for-misbranding-lack-of-written-procedures/ 2017-03-15T23:02:08+00:00 https://biolegacyresearch.com/biolinerx-to-report-annual-2016-results-on-march-23-2017/ 2017-03-16T00:00:00+00:00 https://biolegacyresearch.com/btrumpb-budget-would-double-fda-product-review-fees-leading-to-faster-drug-approvals/ 2017-03-16T00:00:00+00:00 https://biolegacyresearch.com/georgias-visioneering-technologies-successfully-snags-33-3-million-ipo/ 2017-03-16T00:00:00+00:00 https://biolegacyresearch.com/major-reorganization-to-hit-the-nih-deep-cuts-to-affect-thousands-under-budget-plan/ 2017-03-16T00:00:00+00:00 https://biolegacyresearch.com/dnanexus-announces-two-key-executive-appointments/ 2017-03-16T00:00:00+00:00 https://biolegacyresearch.com/this-crispr-startup-co-founded-by-a-30-year-old-just-nabbed-38-million-for-pig-to-human-transplants/ 2017-03-16T00:00:00+00:00 https://biolegacyresearch.com/genenews-announces-contract-with-large-multi-specialty-physician-group-for-use-of-early-cancer-diagnostic-tests/ 2017-03-16T00:00:00+00:00 https://biolegacyresearch.com/300-employees-impacted-as-teva-to-shut-down-or-sell-virginia-plant/ 2017-03-16T00:00:00+00:00 https://biolegacyresearch.com/novabay-to-hold-2016-fourth-quarter-and-full-year-conference-call-on-march-23-2017/ 2017-03-16T00:00:00+00:00 https://biolegacyresearch.com/true-or-false-publishing-negative-results-ruins-your-science-career/ 2017-03-16T00:00:00+00:00 https://biolegacyresearch.com/ema-claries-approach-to-pharmacovigilance-fees/ 2017-03-16T18:54:41+00:00 https://biolegacyresearch.com/uk-regulator-actavis-concordia-reached-deal-to-fix-prices/ 2017-03-16T18:57:10+00:00 https://biolegacyresearch.com/sponsors-request-more-bioequivalence-details-in-guidance/ 2017-03-16T19:00:02+00:00 https://biolegacyresearch.com/ema-to-clarify-anti-cancer-drug-guidance/ 2017-03-16T19:03:02+00:00 https://biolegacyresearch.com/sanders-cummings-request-info-on-fdas-emflaza-approval/ 2017-03-16T22:58:48+00:00 https://biolegacyresearch.com/trump-budget-proposes-steep-hike-in-fda-user-fees/ 2017-03-16T23:02:19+00:00 https://biolegacyresearch.com/acro-drugmakers-request-clearer-fda-guidance-on-multiple-endpoint-trials/ 2017-03-16T23:03:15+00:00 https://biolegacyresearch.com/the-leukemia-lymphoma-society-appoints-as-chief-medical-officer/ 2017-03-17T00:00:00+00:00 https://biolegacyresearch.com/biogen-faces-biggest-one-day-drop/ 2017-03-17T00:00:00+00:00 https://biolegacyresearch.com/infusystem-holdings-inc-to-issue-fourth-quarter-and-year-end-2016-financial-results-on-wednesday-march-22-2017/ 2017-03-17T00:00:00+00:00 https://biolegacyresearch.com/the-hype-behind-massachusetts-biotech-corbus-sole-pipeline-drug/ 2017-03-17T00:00:00+00:00 https://biolegacyresearch.com/magellan-diagnostics-and-partner-to-identify-lead-exposure-in-giant-pandas/ 2017-03-17T00:00:00+00:00 https://biolegacyresearch.com/crippled-bay-area-pharma-threshold-rockets-on-reverse-merger-deal-with-molecular-templates/ 2017-03-17T00:00:00+00:00 https://biolegacyresearch.com/biodelivery-provides-corporate-update-and-reports-fourth-quarter-and-full-year-2016-financial-results/ 2017-03-17T00:00:00+00:00 https://biolegacyresearch.com/disappointment-hits-as-amgens-repatha-prevents-heart-attacks-but-not-deaths/ 2017-03-17T00:00:00+00:00 https://biolegacyresearch.com/agile-therapeutics-inc-announces-a-poster-presentation-of-its-secure-phase-iii-study-at-the-conference/ 2017-03-17T00:00:00+00:00 https://biolegacyresearch.com/ex-google-execs-stroke-prevention-startup-alivecor-gets-30-million/ 2017-03-17T00:00:00+00:00 https://biolegacyresearch.com/why-this-biotech-says-its-close-to-curing-the-type-of-cancer-that-killed/ 2017-03-17T00:00:00+00:00 https://biolegacyresearch.com/penumbra-announces-pricing-of-offering-of-1300000-shares-of-its-common-stock/ 2017-03-17T00:00:00+00:00 https://biolegacyresearch.com/new-wirelessly-powered-scalable-retinal-prosthesis-university-of-california-san-diego-ucsd-reveals/ 2017-03-17T00:00:00+00:00 https://biolegacyresearch.com/bioamber-announces-year-end-operational-and-financial-results-for-2016/ 2017-03-17T00:00:00+00:00 https://biolegacyresearch.com/aslan-to-present-at-biopharma-asia-convention-2017/ 2017-03-17T00:00:00+00:00 https://biolegacyresearch.com/siemens-healthineers-and-heartflow-collaborate-to-provide-solution-that-has-potential-to-lower-cardiac-care-costs/ 2017-03-17T00:00:00+00:00 https://biolegacyresearch.com/eu-court-maintains-suspension-of-ema-document-release/ 2017-03-17T22:12:25+00:00 https://biolegacyresearch.com/valeant-sues-teva-over-onexton-generics/ 2017-03-17T22:13:21+00:00 https://biolegacyresearch.com/four-former-fda-commissioners-urge-against-drug-importation/ 2017-03-17T22:14:30+00:00 https://biolegacyresearch.com/fda-delays-intended-use-rule/ 2017-03-17T22:15:56+00:00 https://biolegacyresearch.com/zoetis-awards-scholarships-to-rising-veterinary-students/ 2017-03-20T00:00:00+00:00 https://biolegacyresearch.com/questions-arise-over-this-bay-area-biotech-ceos-doctorate-degree-and-his-time-at-the-university-of-pennsylvania/ 2017-03-20T00:00:00+00:00 https://biolegacyresearch.com/masimo-announces-ce-marking-of-rad-97-pulse-co-oximeter-and-connectivity-hub-with-noninvasive-blood-pressure/ 2017-03-20T00:00:00+00:00 https://biolegacyresearch.com/fired-was-investigating-new/ 2017-03-20T00:00:00+00:00 https://biolegacyresearch.com/revolution-medicines-appoints-cancer-leader-dr-as-president-of-research-and-development/ 2017-03-20T00:00:00+00:00 https://biolegacyresearch.com/bay-areas-cytomx-surges-as-bristol-myers-squibb-signs-up-for-8-more-projects-with-200-million-upfront-in-deal-totaling-5-billion/ 2017-03-20T00:00:00+00:00 https://biolegacyresearch.com/volitionrx-announces-the-formation-of/ 2017-03-20T00:00:00+00:00 https://biolegacyresearch.com/for-sale-nektar-therapeutics-plans-to-license-hot-new-opioid-drug/ 2017-03-20T00:00:00+00:00 https://biolegacyresearch.com/creative-biomart-launched-a-series-of-activities-and-promotions-recently/ 2017-03-20T00:00:00+00:00 https://biolegacyresearch.com/btrumpsb-expected-policy-changes-have-propelled-these-2-biotechs-to-new-highs/ 2017-03-20T00:00:00+00:00 https://biolegacyresearch.com/fda-grants-regenerative-medicine-designation-to-humacyte-vascular-tissue-therapy/ 2017-03-20T22:03:00+00:00 https://biolegacyresearch.com/fda-approved-over-99-percent-of-expanded-access-requests-in-2016/ 2017-03-20T22:05:00+00:00 https://biolegacyresearch.com/vistapharm-cited-for-contamination-other-violations/ 2017-03-20T22:07:00+00:00 https://biolegacyresearch.com/cellectar-biosciences-further-deepens-intellectual-property-portfolio-with-patent-grant-for-pet-imaging-pdc/ 2017-03-21T00:00:00+00:00 https://biolegacyresearch.com/why-struggling-bristol-myers-squibb-could-take-out-this-danish-biotech-in-major-500m-deal/ 2017-03-21T00:00:00+00:00 https://biolegacyresearch.com/oramed-appoints-as-chief-strategy-officer/ 2017-03-21T00:00:00+00:00 https://biolegacyresearch.com/how-this-drug-candidate-could-be-a-winner-in-gileads-pipeline/ 2017-03-21T00:00:00+00:00 https://biolegacyresearch.com/agilent-enhances-exome-sequencing-for-clinical-research/ 2017-03-21T00:00:00+00:00